10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________________________

FORM 10-Q

_______________________________

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________

Commission file number 1-4347

_______________________________

ROGERS CORPORATION

(Exact Name of Registrant as Specified in its Charter)

_______________________________

Massachusetts	06-0513860
(State or Other Jurisdiction of	(I. R. S. Employer Identification No.)
Incorporation or Organization)

2225 W. Chandler Blvd., Chandler, Arizona 85224-6155

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (480) 917-6000

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)	Name of each exchange on which registered
Capital Stock,	par value $1.00 per share	ROG	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

The number of shares outstanding of the registrant’s capital stock as of April 22, 2024 was 18,656,607.

ROGERS CORPORATION

FORM 10-Q

March 31, 2024

TABLE OF CONTENTS
Part I – Financial Information
	Item 1.	Condensed Consolidated Financial Statements (Unaudited):
		Condensed Consolidated Statements of Operations	4
		Condensed Consolidated Statements of Comprehensive Income (Loss)	5
		Condensed Consolidated Statements of Financial Position	6
		Condensed Consolidated Statements of Cash Flows	8
		Condensed Consolidated Statements of Shareholders’ Equity	7
		Notes to Condensed Consolidated Financial Statements	9
	Item 2.	Management’s Discussion and Analysis of Results of Operations and Financial Position	23
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	29
	Item 4.	Controls and Procedures	30
Part II – Other Information
	Item 1.	Legal Proceedings	31
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	31
	Item 5.	Other	31
	Item 6.	Exhibits	32
		Signatures	33

Forward-Looking Statements

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Refer to “Forward-Looking Statements” in Item 2, Management’s Discussion and Analysis of Results of Operations and Financial Position for additional information.

2

ROGERS CORPORATION

Defined Terms(1)

Term	Definition
4th Amended Credit Agreement	4th Amended and Restated Credit Agreement, dated as of October 16, 2020, among Rogers Corporation, the lenders from time to time party hereto, JPMorgan Chase Bank, N.A., as Administrative Agent and HSBC Bank USA, National Association, Citibank, N.A., Citizens Bank, N.A., PNC Bank, National Association, Wells Fargo Bank, as Co-Syndication Agents
5th Amended Credit Agreement	5th Amended and Restated Credit Agreement, dated as of March 24, 2023, among Rogers Corporation, the lenders from time to time party hereto, JPMorgan Chase Bank, N.A., as Administrative Agent and HSBC Bank USA, National Association, Wells Fargo Bank, National Association, Citibank, N.A. and Citizens Bank, N.A., as Co-Syndication Agents
ADAS	Advanced driver assistance systems
AES	Advanced Electronics Solutions
APAC	Asia - Pacific
ASC	Accounting Standards Codification
ASU	Accounting Standards Update
EMEA	Europe, the Middle East and Africa
EMS	Elastomeric Material Solutions
ESPP	Employee Stock Purchase Plan
EURIBOR	Euro Interbank Offered Rate
EV	Electric vehicles
Exchange Act	Securities Exchange Act of 1934, as amended
FASB	Financial Accounting Standards Board
GAAP	Accounting principles generally accepted in the United States
HEV	Hybrid electric vehicles
LIBOR	London Interbank Offered Rate
NYFRB	Federal Reserve Bank of New York
OECD	Organization for Economic Co-operation and Development
R&D	Research and development
RIC	Rogers Inoac Corporation
RIS	Rogers Inoac Suzhou Corporation
SEC	U.S. Securities and Exchange Commission
SG&A	Selling, general and administrative
SOFR	Secured Overnight Financing Rate
SONIA	Sterling Overnight Index Average
TIBOR	Tokyo Interbank Offered Rate
Union Plan	Rogers Corporation Employees’ Pension Plan
U.S.	United States of America

(1)Certain terms used within this Form 10-Q are defined in the table above.

3

Part I – Financial Information

Item 1.    Financial Statements

ROGERS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(Dollars and shares in millions, except per share amounts)

	Three Months Ended
	March 31, 2024		March 31, 2023
Net sales	$	213.4	$	243.8
Cost of sales	145.2		164.1
Gross margin	68.2		79.7
Selling, general and administrative expenses	47.5		60.1
Research and development expenses	8.9		9.6
Restructuring and impairment charges	0.1		10.5
Other operating (income) expense, net	—		(0.2)
Operating income (loss)	11.7		(0.3)
Equity income in unconsolidated joint ventures	0.3		0.1
Other income (expense), net	0.4		0.1
Interest expense, net	(0.8)		(3.5)
Income (loss) before income taxes	11.6		(3.6)
Income tax expense (benefit)	3.8		(0.1)
Net income (loss)	$	7.8	$	(3.5)
Basic earnings (loss) per share	$	0.42	$	(0.19)
Diluted earnings (loss) per share	$	0.42	$	(0.19)
Shares used in computing:
Basic earnings (loss) per share	18.6		18.6
Diluted earnings (loss) per share	18.7		18.6

The accompanying notes are an integral part of the condensed consolidated financial statements.

4

ROGERS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited)

(Dollars in millions)

	Three Months Ended
	March 31, 2024		March 31, 2023
Net income (loss)	$	7.8	$	(3.5)
Foreign currency translation adjustment	(9.2)		9.7
Pension and other postretirement benefits:
Amortization of loss, net of tax (Note 2)	0.1		—
Other comprehensive income (loss)	(9.1)		9.7
Comprehensive income (loss)	$	(1.3)	$	6.2

The accompanying notes are an integral part of the condensed consolidated financial statements.

5

ROGERS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

(Unaudited)

(Dollars and shares in millions, except par value)

	March 31, 2024		December 31, 2023
Assets
Current assets
Cash and cash equivalents	$	116.9	$	131.7
Accounts receivable, less allowance for credit losses of $1.0 and $1.1	159.2		161.9
Contract assets	40.3		45.2
Inventories, net	150.9		153.5
Asbestos-related insurance receivables, current portion	4.3		4.3
Other current assets	29.8		30.3
Total current assets	501.4		526.9
Property, plant and equipment, net of accumulated depreciation of $386.2 and $385.7	363.4		366.3
Operating lease right-of-use assets	18.6		18.9
Goodwill	357.2		359.8
Other intangible assets, net of amortization	120.3		123.9
Asbestos-related insurance receivables, non-current portion	52.2		52.2
Investments in unconsolidated joint ventures	10.9		11.1
Deferred income taxes	55.7		49.7
Other long-term assets	8.3		8.4
Total assets	$	1,488.0	$	1,517.2
Liabilities and Shareholders’ Equity
Current liabilities
Accounts payable	$	51.7	$	50.3
Accrued employee benefits and compensation	29.5		31.1
Accrued income taxes payable	7.3		2.0
Operating lease obligations, current portion	3.8		3.5
Asbestos-related liabilities, current portion	5.5		5.5
Other accrued liabilities	19.2		24.0
Total current liabilities	117.0		116.4
Borrowings under revolving credit facility	—		30.0
Operating lease obligations, non-current portion	15.1		15.4
Asbestos-related liabilities, non-current portion	56.0		56.0
Non-current income tax	7.2		7.2
Deferred income taxes	22.7		22.9
Other long-term liabilities	10.2		10.3
Commitments and contingencies (Note 6 and Note 10)
Shareholders’ equity
Capital stock - $1 par value; 50.0 authorized shares; 18.7 and 18.6 shares issued and outstanding	18.7		18.6
Additional paid-in capital	153.8		151.8
Retained earnings	1,162.8		1,155.0
Accumulated other comprehensive loss	(75.5)		(66.4)
Total shareholders' equity	1,259.8		1,259.0
Total liabilities and shareholders' equity	$	1,488.0	$	1,517.2

The accompanying notes are an integral part of the condensed consolidated financial statements.

6

ROGERS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(Unaudited)

(Dollars and shares in millions)

	Three Months Ended
	March 31, 2024		March 31, 2023
Capital Stock
Balance, beginning of period	$	18.6	$	18.6
Shares issued for vested restricted stock units, net of shares withheld for taxes	0.1		—
Shares repurchased	—		—
Balance, end of period	18.7		18.6
Additional Paid-In Capital
Balance, beginning of period	151.8		140.7
Shares issued for vested restricted stock units, net of shares withheld for taxes	(1.2)		(2.5)
Equity compensation expense	3.5		2.1
Shares repurchased	(0.3)		—
Balance, end of period	153.8		140.3
Retained Earnings
Balance, beginning of period	1,155.0		1,098.4
Net income (loss)	7.8		(3.5)
Balance, end of period	1,162.8		1,094.9
Accumulated Other Comprehensive Loss
Balance, beginning of period	(66.4)		(85.2)
Other comprehensive income (loss)	(9.1)		9.7
Balance, end of period	(75.5)		(75.5)
Total Shareholders’ Equity	$	1,259.8	$	1,178.3

The accompanying notes are an integral part of the condensed consolidated financial statements.

7

ROGERS CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(Dollars in millions)

	Three Months Ended
	March 31, 2024		March 31, 2023
Operating Activities:
Net income (loss)	$	7.8	$	(3.5)
Adjustments to reconcile net income (loss) to cash provided by operating activities:
Depreciation and amortization	11.3		14.6
Equity compensation expense	3.5		2.1
Deferred income taxes	(5.9)		(7.4)
Equity in undistributed income of unconsolidated joint ventures	(0.3)		(0.1)
Dividends received from unconsolidated joint ventures	1.2		1.5
Other non-cash charges, net	0.1		0.1
Changes in assets and liabilities:
Accounts receivable	(2.8)		2.6
Proceeds from insurance related to operations	4.1		0.5
Contract assets	4.1		(7.9)
Inventories, net	1.3		3.9
Other current assets	0.4		5.4
Accounts payable and other accrued expenses	2.0		(8.8)
Other, net	1.3		(1.2)
Net cash provided by operating activities	28.1		1.8
Investing Activities:
Capital expenditures	(9.4)		(16.4)
Disposition of business	—		1.0
Net cash used in investing activities	(9.4)		(15.4)
Financing Activities:
Repayment of debt principal and finance lease obligations	(30.1)		(25.1)
Line of credit issuance costs	—		(1.8)
Payments of taxes related to net share settlement of equity awards	(1.1)		(2.5)
Share repurchases	(0.3)		—
Net cash used in financing activities	(31.5)		(29.4)
Effect of exchange rate fluctuations on cash	(2.0)		0.8
Net decrease in cash and cash equivalents	(14.8)		(42.2)
Cash and cash equivalents at beginning of period	131.7		235.9
Cash and cash equivalents at end of period	$	116.9	$	193.7
Supplemental Disclosures:
Accrued capital additions	$	5.4	$	2.1
Cash paid during the year for:
Interest, net of amounts capitalized	$	0.5	$	3.5
Income taxes, net of refunds	$	3.1	$	4.0

The accompanying notes are an integral part of the condensed consolidated financial statements.

8

ROGERS CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1 – Basis of Presentation

As used herein, the terms “Company,” “Rogers,” “we,” “us,” “our” and similar terms mean Rogers Corporation and its consolidated subsidiaries, unless the context indicates otherwise.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with GAAP for interim financial information. Accordingly, these statements do not include all of the information and footnotes required by GAAP for complete financial statements. In our opinion, the accompanying condensed consolidated financial statements include all normal recurring adjustments necessary for their fair presentation in accordance with GAAP. All significant intercompany balances and transactions have been eliminated.

Interim results are not necessarily indicative of results for a full year. For further information regarding our accounting policies, refer to the audited consolidated financial statements and footnotes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2023.

Note 2 – Accumulated Other Comprehensive Loss

The changes in accumulated other comprehensive loss by component were as follows:

(Dollars and accompanying footnotes in millions)	Foreign Currency Translation Adjustments		Pension and Other Postretirement Benefits(1)		Total
Balance as of December 31, 2023	$	(56.8)	$	(9.6)	$	(66.4)
Other comprehensive income (loss) before reclassifications	(9.2)		—		(9.2)
Amounts reclassified from accumulated other comprehensive loss	—		0.1		0.1
Net current-period other comprehensive income (loss)	(9.2)		0.1		(9.1)
Balance as of March 31, 2024	$	(66.0)	$	(9.5)	$	(75.5)
Balance as of December 31, 2022	$	(75.6)	$	(9.6)	$	(85.2)
Other comprehensive income (loss) before reclassifications	9.7		—		9.7
Amounts reclassified from accumulated other comprehensive loss	—		—		—
Net current-period other comprehensive income (loss)	9.7		—		9.7
Balance as of March 31, 2023	$	(65.9)	$	(9.6)	$	(75.5)

(1) Net of taxes of $1.8 million for both March 31, 2024 and December 31, 2023. Net of taxes of $1.9 million for both March 31, 2023 and December 31, 2022.

Note 3 – Derivatives and Hedging

The valuation of our derivative contracts used to manage their respective risks is described below:

•Foreign Currency – The fair value of any foreign currency option derivative is based upon valuation models applied to current market information such as strike price, spot rate, maturity date and volatility, and by reference to market values resulting from an over-the-counter market or obtaining market data for similar instruments with similar characteristics.

•Commodity – The fair value of copper derivatives is computed using a combination of intrinsic and time value valuation models, which are collectively a function of five primary variables: price of the underlying instrument, time to expiration, strike price, interest rate and volatility. The intrinsic valuation model reflects the difference between the strike price of the underlying copper derivative instrument and the current prevailing copper prices in an over-the-counter market at period end. The time value valuation model incorporates changes in the price of the underlying copper derivative instrument, the time value of money, the underlying copper derivative instrument’s strike price and the remaining time to the underlying copper derivative instrument’s expiration date from the period end date.

As of March 31, 2024, we did not have any derivative contracts that qualified for hedge accounting treatment.

9

Foreign Currency

During the three months ended March 31, 2024, we entered into U.S. dollar, euro, Korean won, and Japanese yen forward contracts. We entered into these foreign currency forward contracts to mitigate certain global transactional exposures. These contracts do not qualify for hedge accounting treatment. As a result, any fair value adjustments required on these contracts are recorded in “Other income (expense), net” in our condensed consolidated statements of operations in the period in which the adjustment occurred.

As of March 31, 2024, the notional values of the remaining foreign currency forward contracts were as follows:

Notional Values of Foreign Currency Derivatives
USD/CNH	$	20,700,000
EUR/USD	€	14,700,000
KRW/USD	₩	5,372,800,000
JPY/EUR	¥	250,000,000

Commodity

As of March 31, 2024, we had 12 outstanding contracts to hedge exposure related to the purchase of copper in our AES operating segment. These contracts are held with financial institutions and are intended to offset rising copper prices and do not qualify for hedge accounting treatment. As a result, any fair value adjustments required on these contracts are recorded in “Other income (expense), net” in our condensed consolidated statements of operations in the period in which the adjustment occurred.

As of March 31, 2024, the volume of our copper contracts outstanding was as follows:

Volume of Copper Derivatives
April 2024 - June 2024	69 metric tons per month
July 2024 - September 2024	69 metric tons per month
October 2024 - December 2024	69 metric tons per month
January 2025 - March 2025	69 metric tons per month

Effects on Financial Statements

The impacts from our derivative instruments on the statement of operations and statements of comprehensive income were as follows:

		Three Months Ended
(Dollars in millions)	Financial Statement Line Item	March 31, 2024		March 31, 2023
Foreign Currency Contracts
Contracts not designated as hedging instruments	Other income (expense), net	$	(0.1)	$	—
Copper Derivative Contracts
Contracts not designated as hedging instruments	Other income (expense), net	$	—	$	—

The accounting guidance for fair value measurements establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value:

•Level 1 – Quoted prices in active markets for identical assets or liabilities.

•Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

•Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The fair values of derivative instruments measured at fair value on a recurring basis, categorized by contract type and level of inputs used in the valuation, were as follows:

10

	Derivative Instruments at Fair Value as of March 31, 2024
(Dollars in millions)	Level 1		Level 2		Level 3		Total(1)
Foreign currency contracts	$	—	$	(0.1)	$	—	$	(0.1)
Copper derivative contracts	$	—	$	0.5	$	—	$	0.5

	Derivative Instruments at Fair Value as of December 31, 2023
(Dollars in millions)	Level 1		Level 2		Level 3		Total(1)
Foreign currency contracts	$	—	$	(0.2)	$	—	$	(0.2)
Copper derivative contracts	$	—	$	0.4	$	—	$	0.4

(1) All balances were recorded in the “Other current assets” or “Other accrued liabilities” line items in the condensed consolidated statements of financial position.

Note 4 – Inventories

The “Inventories, net” line item in the condensed consolidated statements of financial position consisted of the following:

(Dollars in millions)	March 31, 2024		December 31, 2023
Raw materials	$	76.5	$	71.5
Work-in-process	41.6		45.6
Finished goods	32.8		36.4
Total inventories	$	150.9	$	153.5

Note 5 - Balance Sheet Items

Restricted Cash

Our restricted cash balance, which is subject to contractual restrictions and not readily available, is recorded in the “Cash and cash equivalents” line item in the condensed consolidated statements of financial position, and serves as collateral for letters of credit related to our environmental and workers’ compensation liabilities. Our restricted cash balance as of March 31, 2024 and December 31 2023 was as follows:

(Dollars in millions)	March 31, 2024		December 31, 2023
Restricted Cash	$	2.2	$	2.2

Accounts Receivable

The “Accounts receivable, net” line item in the condensed consolidated statements of financial position consisted of the following:

(Dollars in millions)	March 31, 2024		December 31, 2023
Accounts Receivable - Trade	$	146.6	$	143.2
Accounts Receivable - Other	12.6		18.7
Total	$	159.2	$	161.9

Accounts Payable

The “Accounts payable” line item in the condensed consolidated statements of financial position consisted of the following:

(Dollars in millions)	March 31, 2024		December 31, 2023
Accounts Payable - Trade	$	47.6	$	46.3
Accounts Payable - Other	4.1		4.0
Total	$	51.7	$	50.3

11

Note 6 - Leases

Finance Leases

Amortization expense related to our finance lease right-of-use assets, which is primarily included in the “Cost of sales” line item of the condensed consolidated statements of operations, was immaterial for each of the three-month periods ended March 31, 2024 and 2023. Interest expense related to our finance lease obligations, which is included in the “Interest expense, net” line item of the condensed consolidated statements of operations, was immaterial for each of the three-month periods ended March 31, 2024 and 2023.

Operating Leases

We have operating leases primarily related to manufacturing and R&D facilities as well as vehicles. Our expenses and payments for operating leases were as follows:

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Operating leases expense	$	1.3	$	1.0
Short-term leases expense	$	0.2	$	0.1
Payments on operating lease obligations	$	1.0	$	0.8

Lease Balances in Statements of Financial Position

The assets and liabilities balances related to finance and operating leases reflected in the condensed consolidated statements of financial position were as follows:

(Dollars in millions)	Financial Statement Line Item	March 31, 2024		December 31, 2023
Finance lease right-of-use assets	Property, plant and equipment, net	$	1.4	$	1.5
Operating lease right-of-use assets	Operating lease right-of-use assets	$	18.6	$	18.9
Finance lease obligations, current portion	Other accrued liabilities	$	0.4	$	0.4
Finance lease obligations, non-current portion	Other long-term liabilities	$	1.0	$	1.1
Total finance lease obligations		$	1.4	$	1.5
Operating lease obligations, current portion	Operating lease obligations, current portion	$	3.8	$	3.5
Operating lease obligations, non-current portion	Operating lease obligations, non-current portion	$	15.1	$	15.4
Total operating lease obligations		$	18.9	$	18.9

Net Future Minimum Lease Payments

The following table includes future minimum lease payments under finance and operating leases together with the present value of the net future minimum lease payments as of March 31, 2024:

	Finance						Operating
(Dollars in millions)	Leases Signed		Less: Leases Not Yet Commenced		Leases in Effect		Leases Signed		Less: Leases Not Yet Commenced		Leases in Effect
2024	$	0.3	$	—	$	0.3	$	3.9	$	(0.1)	$	3.8
2025	1.5		(1.1)		0.4		5.2		(1.1)		4.1
2026	1.6		(1.2)		0.4		4.5		(1.2)		3.3
2027	1.4		(1.2)		0.2		3.7		(1.1)		2.6
2028	1.3		(1.2)		0.1		2.6		(0.8)		1.8
Thereafter	5.1		(5.0)		0.1		11.9		(4.8)		7.1
Total lease payments	11.2		(9.7)		1.5		31.8		(9.1)		22.7
Less: Interest	(1.8)		1.7		(0.1)		(6.1)		2.3		(3.8)
Present Value of Net Future Minimum Lease Payments	$	9.4	$	(8.0)	$	1.4	$	25.7	$	(6.8)	$	18.9

12

The following table includes information regarding the lease term and discount rates utilized in the calculation of the present value of net future minimum lease payments:

	March 31, 2024	December 31, 2023
Weighted Average Remaining Lease Term
Finance leases	3.9 years	4.0 years
Operating leases	6.7 years	7.0 years
Weighted Average Discount Rate
Finance leases	4.22%	4.14%
Operating leases	5.37%	5.35%

Note 7 – Goodwill and Other Intangible Assets

Goodwill

The changes in the net carrying amount of goodwill by operating segment were as follows:

(Dollars in millions)	Advanced Electronics Solutions		Elastomeric Material Solutions		Other		Total
December 31, 2023	$	117.7	$	239.9	$	2.2	$	359.8
Foreign currency translation adjustment	(1.5)		(1.1)		—		$	(2.6)
March 31, 2024	$	116.2	$	238.8	$	2.2	$	357.2

Other Intangible Assets

The carrying amount of other intangible assets were as follows:

	March 31, 2024						December 31, 2023
(Dollars in millions)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Customer relationships	$	177.0	$	91.4	$	85.6	$	177.9	$	90.0	$	87.9
Technology	76.8		58.6		18.2		77.4		58.1		19.3
Trademarks and trade names	19.3		7.4		11.9		19.4		7.4		12.0
Covenants not to compete	1.3		1.0		0.3		1.3		0.9		0.4
Total definite-lived other intangible assets	274.4		158.4		116.0		276.0		156.4		119.6
Indefinite-lived other intangible asset	4.3		—		4.3		4.3		—		4.3
Total other intangible assets	$	278.7	$	158.4	$	120.3	$	280.3	$	156.4	$	123.9

In the table above, gross carrying amounts and accumulated amortization may differ from prior periods due to foreign exchange rate fluctuations.

Amortization expense was $3.1 million and $3.3 million for the three months ended March 31, 2024 and 2023, respectively. The estimated future amortization expense is $9.3 million, $10.8 million, $10.4 million, $10.0 million, and $7.8 million in 2024, 2025, 2026, 2027 and 2028, respectively. These amounts could vary based on changes in foreign currency exchange rates.

The weighted average amortization period as of March 31, 2024, by definite-lived other intangible asset class, is presented in the table below:

	Weighted Average Remaining Amortization Period
Customer relationships	7.3 years
Technology	3.2 years
Trademarks and trade names	9.8 years
Covenants not to compete	0.4 years
Total definite-lived other intangible assets	6.9 years

13

Note 8 – Pension Benefits and Other Postretirement Benefits

Pension and Other Postretirement Benefit Plans

As of March 31, 2024, we had one qualified noncontributory defined benefit pension plan, the Union Plan, which was frozen and ceased accruing benefits in 2013. Additionally, we sponsor other postretirement benefit plans, including multiple fully insured or self-funded medical plans and life insurance plans for certain retirees. The measurement date for all plans is December 31st for each respective plan year.

Components of Net Periodic Benefit Cost (Credit)

The components of net periodic benefit (credit) cost were as follows:

	Pension Benefits
	Three Months Ended
	March 31,
(Dollars in millions)	2024		2023
Interest cost	0.2		0.3
Expected return of plan assets	(0.3)		(0.4)
Amortization of net loss (gain)	0.1		0.1
Net periodic benefit cost (credit)	$	—	$	—

Employer Contributions

There were no required or voluntary contributions made to the Union Plan for each of the three months ended March 31, 2024 and 2023. Additionally, we are not required to make additional contributions to the Union Plan for the remainder of 2024.

As there is no funding requirement for the other postretirement benefit plans, we funded these benefit payments as incurred, which were immaterial for each of the three months ended March 31, 2024 and 2023, using cash from operations.

Note 9 – Debt

On March 24, 2023, we entered into a Fifth Amended Credit Agreement with each of the lenders party thereto, JPMorgan Chase Bank, N.A. as administrative agent, and HSBC Bank USA, National Association, Wells Fargo Bank, National Association, Citibank, N.A. and Citizens Bank, N.A. as Co-Syndication Agents. The Fifth Amended Credit Agreement amends and restates the Fourth Amended Credit Agreement, and provides for (1) a revolving credit facility with up to $450.0 million of revolving loans, with sub-limits for multicurrency borrowings, letters of credit and swing-line notes, and (2) a $225.0 million expansion feature. Borrowings may be used to finance working capital needs, for letters of credit and for general corporate purposes in the ordinary course of business, including the financing of permitted acquisitions (as defined in the Fifth Amended Credit Agreement). The Fifth Amended Credit Agreement extends the maturity, the date on which all amounts borrowed or outstanding under the Fifth Amended Credit Agreement are due, from March 31, 2024 to March 24, 2028.

All obligations under the Fifth Amended Credit Agreement are guaranteed by each of our existing and future material domestic subsidiaries, as defined in the Fifth Amended Credit Agreement (the Guarantors). The obligations are also secured by a Fifth Amended and Restated Pledge and Security Agreement, dated as of March 24, 2023, entered into by us and the Guarantors which grants to the administrative agent, for the benefit of the lenders, a security interest, subject to certain exceptions, in substantially all of the non-real estate assets of ours and the Guarantors. These assets include, but are not limited to, receivables, equipment, intellectual property, inventory, and stock in certain subsidiaries.

Borrowings under the Fifth Amended Credit Agreement bear interest based on one of two options. Alternate base rate loans will bear interest at a rate that includes a base reference rate plus a spread of 62.5 to 100.0 basis points, depending on our leverage ratio. The base reference rate will be the greater of the (1) prime rate, (2) federal funds effective rate plus 50 basis points, and (3) one-month Term SOFR plus 110 basis points. Loans bearing an interest rate determined by reference to the Adjusted Term SOFR Rate, the Adjusted EURIBOR, or the Adjusted TIBOR (each as defined in the Fifth Amended Credit Agreement) will bear interest based on the screen rate plus a spread of 162.5 to 200.0 basis points, depending on our leverage ratio. Based on our leverage ratio as of March 31, 2024, the spread was 162.5 basis points.

In addition to interest payable on the principal amount of indebtedness outstanding, we incur an annual fee of 25 to 35 basis points (based upon our leverage ratio), paid quarterly, of the unused amount of the lenders’ commitments under the Fifth Amended Credit Agreement.

The Fifth Amended Credit Agreement contains customary representations and warranties, covenants, mandatory prepayments and events of default under which the Company’s payment obligations may be accelerated. The financial covenants include a

14

requirement to maintain (1) a total net leverage ratio of no more than 3.25 to 1.00, subject to a one-time election to increase the maximum total net leverage ratio to 3.75 to 1.00 for one fiscal year in connection with a permitted acquisition, and (2) an interest coverage ratio of no less than 3.00 to 1.00. We are permitted to net up to $50.0 million of unrestricted domestic cash and cash equivalents in the calculation of the total net leverage ratio. The Fifth Amended Credit Agreement generally permits us to pay cash dividends to our shareholders, provided that (i) no default or event of default has occurred and is continuing or would result from the dividend payment and (ii) our total net leverage ratio does not exceed 2.75 to 1.00. If our total net leverage ratio exceeds 2.75 to 1.00, we may nonetheless make up to $20.0 million in restricted payments, including cash dividends, during the fiscal year, provided that no default or event of default has occurred and is continuing or would result from the payments. Our total net leverage ratio did not exceed 2.75 to 1.00 and our interest coverage ratio was greater than or equal to 3.00 to 1.00 as of March 31, 2024.

There were no borrowings under the Fifth Amended Credit Agreement during the three months ended March 31, 2024 or the three months ended March 31, 2023. We are not required to make any quarterly principal payments under the Fifth Amended Credit Agreement. We made a $30.0 million discretionary principal payment during the three months ended March 31, 2024, and we made a $25.0 million discretionary principal payment during the three months ended March 31, 2023.

We had no outstanding borrowings under our revolving credit facility as of March 31, 2024, and $30.0 million as of December 31, 2023. We had $2.0 million and $2.1 million of outstanding line of credit issuance costs as of March 31, 2024 and December 31, 2023, respectively, which will be amortized over the life of the Fifth Amended Credit Agreement.

Note 10 – Commitments and Contingencies

We are currently engaged in the following material environmental and legal proceedings:

Asbestos

Overview

We, like many other industrial companies, have been named as a defendant in a number of lawsuits filed in courts across the country by persons alleging personal injury from exposure to products containing asbestos. We have never mined, milled, manufactured or marketed asbestos; rather, we made and provided to industrial users a limited number of products that contained encapsulated asbestos, but we stopped manufacturing these products in the late 1980s. Most of the claims filed against us involve numerous defendants, sometimes as many as several hundred. In virtually all of the cases against us, the plaintiffs are seeking unspecified damages above a jurisdictional minimum against multiple defendants who may have manufactured, sold or used asbestos-containing products to which the plaintiffs were allegedly exposed and from which they purportedly suffered injury. Most of these cases are being litigated in Maryland, Illinois, Missouri and New York; however, we are also defending cases in other states. We continue to vigorously defend these cases, primarily on the basis of the plaintiffs’ inability to establish compensable loss as a result of exposure to our products. The indemnity and defense costs of our asbestos-related product liability litigation to date have been substantially covered by insurance.

The following table summarizes the change in number of asbestos claims outstanding for the three months ended March 31, 2024:

	Asbestos Claims
Claims outstanding as of January 1, 2024	506
New claims filed	35
Pending claims concluded(1)	(36)
Claims outstanding as of March 31, 2024	505

(1) For the three months ended March 31, 2024, 32 claims were dismissed and 4 claims were settled. Settlements totaled approximately $1.5 million for the three months ended March 31, 2024.

Impact on Financial Statements

We recognize a liability for asbestos-related contingencies that are probable of occurrence and reasonably estimable. In connection with the recognition of liabilities for asbestos-related matters, we record asbestos-related insurance receivables that are deemed probable.

The liability projection period covers all current and future indemnity and defense costs through 2064, which represents the expected end of our asbestos liability exposure with no further ongoing claims expected beyond that date. This conclusion was based on our history and experience with the claims data, the diminished volatility and consistency of observable claims data, the period of time that has elapsed since we stopped manufacturing products that contained encapsulated asbestos and an expected downward trend in claims due to the average age of our claimants, which is approaching the average life expectancy.

15

To date, the indemnity and defense costs of our asbestos-related product liability litigation have been substantially covered by insurance. Although we have exhausted coverage under some of our insurance policies, we believe that we have applicable primary, excess and/or umbrella coverage for claims arising with respect to most of the years during which we manufactured and marketed asbestos-containing products. In addition, we have entered into a cost sharing agreement with most of our primary, excess and umbrella insurance carriers to facilitate the ongoing administration and payment of claims covered by the carriers. The cost sharing agreement may be terminated by any party, but will continue until a party elects to terminate it. As of the filing date for this report, the agreement has not been terminated, and no carrier had informed us that it intends to terminate the agreement. We expect to continue to exhaust individual primary, excess and umbrella coverages over time, and there is no assurance that such exhaustion will not accelerate due to additional claims, damages and settlements or that coverage will be available as expected. We are responsible for uninsured indemnity and defense costs, and we incurred an immaterial amount of expenses for each of the three month periods ended March 31, 2024 and 2023, respectively, related to such costs.

The amounts recorded for the asbestos-related liability and the related insurance receivables are based on facts known at the time and a number of assumptions. However, projecting for future events, such as the number of new claims to be filed each year, the average cost of disposing of such claims, the length of time it takes to dispose of such claims, coverage issues among insurers and the continuing solvency of various insurance companies, as well as the numerous uncertainties surrounding asbestos litigation in the United States, could cause the actual liability and insurance recoveries for us to be higher or lower than those projected or recorded. The full extent of our financial exposure to asbestos-related litigation remains very difficult to estimate and could include both compensatory and punitive damage awards.

Changes recorded in the estimated liability and estimated insurance recovery based on projections of asbestos litigation and corresponding insurance coverage, result in the recognition of expense or income.

Our projected asbestos-related liabilities and insurance receivables were as follows:

(Dollars in millions)	March 31, 2024		December 31, 2023
Asbestos-related liabilities	$	61.5	$	61.5
Asbestos-related insurance receivables	$	56.5	$	56.5

Environmental Voluntary Corrective Action Program

Our location in Rogers, Connecticut is part of the Connecticut Voluntary Corrective Action Program (VCAP). As part of this program, we partnered with the Connecticut Department of Energy and Environmental Protection (CT DEEP) to determine the corrective actions to be taken at the site related to contamination issues. We evaluated this matter and completed internal due diligence work related to the site in the fourth quarter of 2015. Remediation activities on the site are ongoing and are recorded as reductions to the accrual as they are incurred. We have incurred $2.0 million of aggregate remediation costs through March 31, 2024, and the accrual for future remediation efforts is $0.7 million.

Other Matters

In addition to the above issues, the nature and scope of our business brings us in regular contact with the general public and a variety of businesses and government agencies. Such activities inherently subject us to the possibility of litigation, including environmental and product liability matters that are defended and handled in the ordinary course of business. We have established accruals for matters for which management considers a loss to be probable and reasonably estimable. It is the opinion of management that facts known at the present time do not indicate that such litigation will have a material adverse impact on our results of operations, financial position or cash flows.

16

Note 11 – Earnings Per Share

Basic earnings per share is based on the weighted average number of common shares outstanding. Diluted earnings per share is based on the weighted average number of common shares outstanding and all dilutive potential common shares outstanding.

The following table sets forth the computation of basic and diluted earnings per share:

(Dollars and shares in millions, except per share amounts)	Three Months Ended
	March 31, 2024		March 31, 2023
Numerator:
Net income (loss)	$	7.8	$	(3.5)
Denominator:
Weighted-average shares outstanding - basic	18.6		18.6
Effect of dilutive shares	0.1		—
Weighted-average shares outstanding - diluted	18.7		18.6
Basic earnings (loss) per share	$	0.42	$	(0.19)
Diluted earnings (loss) per share	$	0.42	$	(0.19)

Dilutive shares are calculated using the treasury stock method and primarily include unvested restricted stock units. Anti-dilutive shares are excluded from the calculation of diluted shares and diluted earnings per share. For the three months ended March 31, 2024 and 2023, an immaterial number of shares were excluded.

Note 12 – Capital Stock and Equity Compensation

Share Repurchases

In 2015, we initiated a share repurchase program (the “Program”) of up to $100.0 million of the Company’s capital stock to mitigate the dilutive effects of stock option exercises and vesting of restricted stock units granted by the Company, in addition to enhancing shareholder value. The Program has no expiration date and may be suspended or discontinued at any time without notice. For the three months ended March 31, 2024, we purchased 1,500 shares for a total value of $0.2 million using cash from operations and cash on hand. As of March 31, 2024, $23.8 million remained available to purchase under the Program. Our stock repurchases may occur from time to time through open market purchases, privately negotiated transactions or plans designed to comply with Rule 10b5-1 promulgated under the Exchange Act.

(Dollars in millions, except shares and per share amounts)
Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet be Purchased under the Plans or Programs
March 1, 2024 to March 31, 2024	1,500	$	109.92	1,500	$	23.8

Equity Compensation

Performance-Based Restricted Stock Units

As of March 31, 2024, we had outstanding performance-based restricted stock units with a market condition from 2024 and 2023. These awards generally cliff vest at the end of a three-year measurement period. However, employees whose employment terminates during the measurement period due to death, disability, or, in certain cases, retirement may receive a pro-rata payout based on the number of days they were employed during the measurement period. Participants are eligible to be awarded shares ranging from 0% to 200% of the original award amount, based on certain defined performance measures.

The performance-based restricted stock units with a market condition have one measurement criterion: the three-year total shareholder return (“TSR”) on our capital stock as compared to that of a specified group of peer companies. The fair value of this measurement criterion was determined on the grant date using a Monte Carlo simulation valuation model. We recognize compensation expense on all of these awards on a straight-line basis over the vesting period with no changes for final projected payout of the awards. We account for forfeitures as they occur.

17

The following table sets forth the assumptions used in the Monte Carlo calculation for each material award granted in 2024 and 2023:

	February 19, 2024	February 13, 2024	February 9, 2023
Expected volatility	46.3%	46.2%	53.2%
Expected term (in years)	2.9	2.9	2.9
Risk-free interest rate	4.35%	4.35%	4.08%

Expected volatility – In determining expected volatility, we have considered a number of factors, including historical volatility.

Expected term – We use the vesting period of the award to determine the expected term assumption for the Monte Carlo simulation valuation model.

Risk-free interest rate – We use an implied “spot rate” yield on U.S. Treasury Constant Maturity rates as of the grant date for our assumption of the risk-free interest rate.

Expected dividend yield – We do not currently pay dividends on our capital stock; therefore, a dividend yield of 0% was used in the Monte Carlo simulation valuation model.

As of March 31, 2024, we had outstanding performance-based restricted stock units with a performance condition from 2024. These awards generally cliff vest at the end of a two-year performance period. However, employees whose employment terminates during the measurement period due to death, disability, or, in certain cases, retirement may receive a pro-rata payout based on the number of days they were employed during the measurement period. Participants are eligible to be awarded shares ranging from 0% to 200% of the original award amount, based on certain defined performance measures.

The performance-based restricted stock units with a performance condition have one measurement criterion: 2025 net revenue. The fair value of these awards was determined based on the market value of the underlying stock price at the grant date with cumulative compensation expense recognized to-date being increased or decreased based on the changes in the forecasted payout percentage as of the end of each reporting period. We account for forfeitures as they occur.

A summary of activity of the outstanding performance-based restricted stock units for the three months ended March 31, 2024 is presented below:

	Performance-Based Restricted Stock Units
Awards outstanding as of December 31, 2023	73,528
Awards granted	79,700
Stock issued	—
Awards cancelled	(26,737)
Awards outstanding as of March 31, 2024	126,491

We recognized $1.3 million and $0.1 million of compensation expense for performance-based restricted stock units for the three months ended March 31, 2024 and 2023, respectively.

Time-Based Restricted Stock Units

As of March 31, 2024, we had time-based restricted stock unit awards from 2024, 2023, 2022 and 2021 outstanding. The outstanding awards all ratably vest on the first, second and third anniversaries of the original grant date. However, employees whose employment terminates during the measurement period due to death, disability, or, in certain cases, retirement may receive a pro-rata payout based on the number of days they were employed subsequent to the last grant anniversary date. Each time-based restricted stock unit represents a right to receive one share of Rogers’ capital stock at the end of the vesting period. The fair value of the award is determined by the market value of the underlying stock price at the grant date. We recognize compensation expense on all of these awards on a straight-line basis over the vesting period. We account for forfeitures as they occur.

18

A summary of activity of the outstanding time-based restricted stock units for the three months ended March 31, 2024 is presented below:

	Time-Based Restricted Stock Units
Awards outstanding as of December 31, 2023	100,999
Awards granted	67,480
Stock issued	(34,261)
Awards cancelled	(3,688)
Awards outstanding as of March 31, 2024	130,530

We recognized $1.9 million and $2.1 million of compensation expense for time-based restricted stock units for the three months ended March 31, 2024 and 2023, respectively.

Deferred Stock Units

We grant deferred stock units to non-management directors. These awards are fully vested on the date of grant and the related shares are generally issued on the 13-month anniversary of the grant date unless the individual elects to defer the receipt of those shares. Each deferred stock unit results in the issuance of one share of Rogers’ capital stock. The grant of deferred stock units is typically done annually during the second quarter of each year. The fair value of the award is determined by the market value of the underlying stock price at the grant date.

A summary of activity of the outstanding deferred stock units for the three months ended March 31, 2024 is presented below:

	Deferred Stock Units
Awards outstanding as of December 31, 2023	8,100
Awards granted	450
Stock issued	(950)
Awards outstanding as of March 31, 2024	7,600

We recognized an immaterial amount of compensation expense and no compensation expense for deferred stock units for the three months ended March 31, 2024 and 2023, respectively.

Employee Stock Purchase Plan

We have an ESPP that allows eligible employees to purchase, through payroll deductions, shares of our capital stock at a discount to fair market value. The ESPP has two six-month offering periods each year, the first beginning in mid-December and ending in mid-June and the second beginning in mid-June and ending in mid-December. The ESPP contains a look-back feature that allows the employee to acquire shares of our capital stock at a 15% discount from the underlying market price at the beginning or end of the applicable period, whichever is lower. We recognize compensation expense on this plan ratably over the offering period based on the fair value of the anticipated number of shares that will be issued at the end of each offering period. Compensation expense is adjusted at the end of each offering period for the actual number of shares issued. Fair value is determined based on two factors: (i) the 15% discount on the underlying stock’s market value on the first day of the applicable offering period, and (ii) the fair value of the look-back feature determined by using the Black-Scholes model. We recognized $0.2 million of compensation expense associated with the ESPP for the three months ended March 31, 2024.

Note 13 – Operating Segment Information

Our reporting structure is comprised of the following strategic operating segments: AES and EMS. The remaining operations, which represent our non-core businesses, are reported in the Other operating segment.

Our AES operating segment designs, develops, manufactures and sells circuit materials, ceramic substrate materials, busbars and cooling solutions for applications in EV/HEV, automotive (e.g., ADAS), aerospace and defense (e.g., antenna systems, communication systems and phased array radar systems), renewable energy (e.g., wind and solar), wireless infrastructure (e.g., power amplifiers, antennas and small cells), mass transit, industrial (e.g., variable frequency drives), connected devices (e.g., mobile internet devices and thermal solutions) and wired infrastructure (e.g., computing and internet protocol infrastructure) markets.

Our EMS operating segment designs, develops, manufactures and sells engineered material solutions for a wide variety of applications and markets. These include polyurethane and silicone materials used in cushioning, gasketing and sealing, and vibration management applications for EV/HEV, general industrial, portable electronics, automotive, mass transit, aerospace and defense, footwear and impact mitigation markets; customized silicones used in flex heater and semiconductor thermal applications for EV/HEV, general industrial, portable electronics, automotive, mass transit, aerospace and defense and medical

19

markets; and polytetrafluoroethylene and ultra-high molecular weight polyethylene materials used in wire and cable protection, electrical insulation, conduction and shielding, hose and belt protection, vibration management, cushioning, gasketing and sealing, and venting applications for EV/HEV, general industrial, automotive and aerospace and defense markets.

Our Other operating segment consists of elastomer components for applications in the general industrial market, as well as elastomer floats for level sensing in fuel tanks, motors, and storage tanks applications in the general industrial and automotive markets.

The following table presents a disaggregation of revenue from contracts with customers and other pertinent financial information, for the periods indicated; inter-segment sales have been eliminated from the net sales data:

(Dollars in millions)	Advanced Electronics Solutions		Elastomeric Material Solutions		Other		Total
Three Months Ended March 31, 2024
Net sales - recognized over time	$	46.4	$	1.8	$	5.4	$	53.6
Net sales - recognized at a point in time	75.7		83.9		0.2		159.8
Total net sales	$	122.1	$	85.7	$	5.6	$	213.4
Operating income	$	4.4	$	5.3	$	2.0	$	11.7
Three Months Ended March 31, 2023
Net sales - recognized over time	$	62.4	$	9.0	$	3.9	$	75.3
Net sales - recognized at a point in time	73.5		93.2		1.8		168.5
Total net sales	$	135.9	$	102.2	$	5.7	$	243.8
Operating income	$	(5.5)	$	3.2	$	2.0	$	(0.3)

Net sales by operating segment and by geographic area were as follows:

(Dollars in millions)	Net Sales(1)
Region/Country	Advanced Electronics Solutions		Elastomeric Material Solutions		Other		Total
Three Months Ended March 31, 2024
United States	$	20.4	$	33.1	$	1.0	$	54.5
Other Americas	0.6		3.9		0.1		4.6
Total Americas	21.0		37.0		1.1		59.1
China	34.3		20.4		1.6		56.3
Other APAC	23.7		6.6		1.1		31.4
Total APAC	58.0		27.0		2.7		87.7
Germany	21.9		7.9		0.2		30.0
Other EMEA	21.2		13.8		1.6		36.6
Total EMEA	43.1		21.7		1.8		66.6
Total net sales	$	122.1	$	85.7	$	5.6	$	213.4
Three Months Ended March 31, 2023
United States	$	21.5	$	41.9	$	1.1	$	64.5
Other Americas	2.4		9.2		0.1		11.7
Total Americas	23.9		51.1		1.2		76.2
China	38.4		20.2		2.4		61.0
Other APAC	24.9		7.0		0.5		32.4
Total APAC	63.3		27.2		2.9		93.4
Germany	24.0		8.0		0.1		32.1
Other EMEA	24.7		15.9		1.5		42.1
Total EMEA	48.7		23.9		1.6		74.2
Total net sales	$	135.9	$	102.2	$	5.7	$	243.8

20

(1)Net sales are allocated to countries based on the location of the customer. The table above lists individual countries with 10% or more of net sales for the periods indicated.

We have contract assets primarily related to unbilled revenue for revenue recognized related to products that are deemed to have no alternative use whereby we have the right to payment. Revenue is recognized in advance of billing to the customer in these circumstances as billing is typically performed at the time of shipment to the customer. The unbilled revenue is included in contract assets on the condensed consolidated statements of financial position.

Contract assets by operating segment were as follows:

(Dollars in millions)	March 31, 2024		December 31, 2023
Advanced Electronics Solutions	$	35.6	$	41.4
Elastomeric Material Solutions	0.7		0.4
Other	4.0		3.4
Total contract assets	$	40.3	$	45.2

We did not have any contract liabilities as of March 31, 2024 or December 31, 2023. No impairment losses were recognized for each of the three month periods ended March 31, 2024 and 2023, respectively, on any receivables or contract assets arising from our contracts with customers.

Note 14 – Supplemental Financial Information

Restructuring and Impairment Charges

The components of the “Restructuring and impairment charges” line item in the condensed consolidated statements of operations were as follows:

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Restructuring charges
Global workforce reduction	$	—	$	7.0
Facility consolidations	0.1		3.5
Total restructuring charges	$	0.1	$	10.5
Total restructuring and impairment charges	$	0.1	$	10.5

Restructuring Charges - Global Workforce Reduction

On February 16, 2023, we announced a plan to reduce our global workforce that was substantially completed in the first half of 2023, and concluded in the fourth quarter of 2023. The plan significantly reduced our manufacturing costs and operating expenses. We incurred $8.8 million in pre-tax restructuring charges related to this plan, all of which was in the form of cash-based expenditures and substantially all of which were related to employee severance and other termination benefits.

Restructuring Charges - Facility Consolidations

In late 2022 and early 2023, we announced our intention to exit certain facilities in the U.S. and Asia. The plan significantly reduced our manufacturing costs and operating expenses. We have incurred $8.2 million in pre-tax restructuring charges to-date related to these facility consolidations, most of which were in the form of accelerated depreciation.

As part of our facility consolidations plan, in February 2023, we entered into an asset purchase agreement to sell our high-performance engineered cellular elastomer business in our EMS operating segment for a purchase price of $1.8 million. The first phase of the deal, which pertained to the net assets other than the land and building, was completed in late March 2023, while the second phase, which pertained to the sale of the land and building, was completed in early September 2023. Of the $1.8 million purchase price, $1.0 million and $0.8 million were allocated to the first and second phases of the deal, respectively. The first phase of the deal included $3.7 million in assets and $3.1 million in liabilities. The assets were primarily comprised of accounts receivable, contract assets and inventories, while the liabilities were primarily comprised of accounts payable and other accrued liabilities, along with the previously recognized accrual against the net assets of the business based on the estimated fair value of the business in December 2022. We incurred $1.2 million of selling costs in 2023, which were recorded in “Selling, general and administrative expenses” in our condensed consolidated statements of operations.

21

As of March 31, 2024 we recognized $13.1 million of assets held for sale within the “Other current assets” financial statement line item of our condensed consolidated statements of financial position, representing the land and building at our Price Road facility in Chandler, Arizona. We still expect the sale of this facility to be completed in the second quarter of 2024. In September 2023, we entered into an agreement to sell one of our Suzhou, China facilities, which had a carrying value of $3.0 million, for $6.8 million resulting in a pre-tax gain of $1.9 million, inclusive of selling and disposal costs. The sale was completed in December 2023. The net impact of this transaction was recorded in the “Other operating (income) expense, net” line item in the condensed consolidated statements of operations.

Allocation of Restructuring and Impairment Charges to Operating Segments

The following table summarizes the allocation of restructuring and impairment charges to our operating segments:

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Advanced Electronics Solutions
Allocated restructuring charges	$	0.1	$	5.4
Elastomeric Material Solutions
Allocated restructuring charges	—		5.1
Total restructuring and impairment charges	$	0.1	$	10.5

Other Operating (Income) Expense, Net

The components of “Other operating (income) expense, net” line item in the condensed consolidated statements of operations, were as follows:

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
UTIS fire
Professional services	$	—	$	0.3
Insurance recoveries	—		(0.5)
Total UTIS fire	—		(0.2)
Total other operating (income) expense, net	$	—	$	(0.2)

In early February 2021, there was a fire at our UTIS manufacturing facility in Ansan, South Korea, which manufactures eSorba® polyurethane foams used in portable electronics and display applications. The site was safely evacuated and there were no reported injuries; however, there was extensive damage to the manufacturing site and some damage to nearby property. Commercial production at our new location in Siheung, South Korea commenced in late January 2023.

In connection with the UTIS fire, we recognized insurance recoveries of $0.5 million related to our ongoing insurance claims for business interruption and property damage for the three months ended March 31, 2023. We incurred $0.3 million for various professional services for the three months ended March 31, 2023, in connection with the pursuit of our insurance claims.

Interest Expense, Net

The components of “Interest expense, net” line item in the condensed consolidated statements of operations, were as follows:

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Interest on revolving credit facility	$	(0.5)	$	(3.4)
Line of credit fees	(0.3)		(0.3)
Debt issuance amortization costs	(0.1)		(0.3)
Interest income	0.1		0.5
Total interest expense, net	$	(0.8)	$	(3.5)

Note 15 – Income Taxes

The below discussion of the effective tax rate for the periods presented in the consolidated statements of operations is in comparison to the 21% U.S. statutory federal income tax rate.

22

Our effective tax rate was 32.8% in the first quarter of 2024. During the first quarter of 2024, our effective tax rate was unfavorably impacted primarily by the write-off of deferred tax assets related to stock compensation.

During the first quarter of 2023, our effective tax rate was 3.5%. During the first quarter of 2023, our effective tax rate was unfavorably impacted primarily by an increase in the valuation allowance attributable to loss jurisdictions in which no benefit is anticipated to be realized.

The OECD Pillar 2 guidelines published to date include transition and safe harbor rules around the implementation of the Pillar 2 global minimum tax of 15%. Based on current enacted legislation effective in 2024 and our structure, we do not expect a material impact in 2024. We are monitoring developments and evaluating the impacts these new rules will have on our future effective income tax rate, tax payments, financial condition, and results of operations.

Note 16 - Recent Accounting Standards

Recently Issued Standards

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU 2023-07 enhances segment reporting under Topic 280 by expanding the breadth and frequency of segment disclosures. This amendment will improve the disclosures about a public entity’s reportable segments and address requests from investors for additional, more detailed information about a reportable segment’s expenses. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. Adoption of the standard requires using the retrospective approach. We are currently evaluating the potential impact of adopting this guidance on our consolidated financial statements and accompanying notes.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments in this update address investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This update also includes certain other amendments to improve the effectiveness of income tax disclosures. The ASU is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. Adoption of the standard should be applied on a prospective basis and retrospective application to all periods presented is permitted. We are currently evaluating the potential impact of adopting this guidance on our consolidated financial statements and accompanying notes.

Item 2.    Management’s Discussion and Analysis of Results of Operations and Financial Position

As used herein, the “Company,” “Rogers,” “we,” “us,” “our” and similar terms include Rogers Corporation and its subsidiaries, unless the context indicates otherwise.

Forward-Looking Statements

This Quarterly Report on Form 10-Q includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. Such statements are generally accompanied by words such as “anticipate,” “assume,” “believe,” “could,” “estimate,” “expect,” “foresee,” “goal,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “should,” “seek,” “target” or similar expressions that convey uncertainty as to future events or outcomes. Forward-looking statements are based on assumptions and beliefs that we believe to be reasonable; however, assumed facts almost always vary from actual results, and the differences between assumed facts and actual results could be material depending upon the circumstances. Where we express an expectation or belief as to future results, that expectation or belief is expressed in good faith and based on assumptions believed to have a reasonable basis. We cannot assure you, however, that the stated expectation or belief will occur or be achieved or accomplished. Among the factors that could cause our results to differ materially from those indicated by forward-looking statements are risks and uncertainties inherent in our business including, without limitation:

•failure to capitalize on, volatility within, or other adverse changes with respect to our growth drivers, such as delays in adoption or implementation of new technologies;

•failure to successfully execute on our long-term growth strategy as a standalone company;

•uncertain business, economic and political conditions in the U.S. and abroad, particularly in China, Germany, Belgium, England, South Korea and Hungary where we maintain significant manufacturing, sales or administrative operations;

•the trade policy dynamics between the U.S. and China reflected in trade agreement negotiations, the imposition of tariffs and other trade restrictions, as well as the potential for U.S.-China supply chain decoupling;

•fluctuations in foreign currency exchange rates;

•our ability to develop innovative products and the extent to which they are incorporated into end-user products and systems;

•the extent to which end-user products and systems incorporating our products achieve commercial success;

•the ability and willingness of our sole or limited source suppliers to deliver certain key raw materials, including commodities, to us in a timely and cost-effective manner;

23

•intense global competition affecting both our existing products and products currently under development;

•business interruptions due to catastrophes or other similar events, such as natural disasters, war, terrorism or public health crises;

•the impact of sanctions, export controls and other foreign asset or investment restriction;

•failure to realize, or delays in the realization of, anticipated benefits of acquisitions and divestitures due to, among other things, the existence of unknown liabilities or difficulty integrating acquired businesses;

•our ability to attract and retain management and skilled technical personnel;

•our ability to protect our proprietary technology from infringement by third parties and/or allegations that our technology infringes third party rights;

•changes in effective tax rates or tax laws and regulations in the jurisdictions in which we operate;

•failure to comply with financial and restrictive covenants in our credit agreement or restrictions on our operational and financial flexibility due to such covenants;

•the outcome of ongoing and future litigation, including our asbestos-related product liability litigation;

•changes in environmental laws and regulations applicable to our business; and

•disruptions in, or breaches of, our information technology systems.

Our forward-looking statements are expressly qualified by these cautionary statements, which you should consider carefully, along with the risks discussed in this section and elsewhere in this report, including under the section entitled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023 (the Annual Report) and our other reports filed with the SEC, any of which could cause actual results to differ materially from historical results or anticipated results. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law.

The following discussion and analysis of our financial condition and results of operations should be read together with our condensed consolidated financial statements and the related notes that appear elsewhere in this Form 10-Q along with our audited consolidated financial statements and the related notes thereto in our Annual Report.

Company Overview and Strategy

We design, develop, manufacture and sell high-performance and high-reliability engineered materials and components to meet our customers’ demanding challenges. We operate two strategic operating segments: AES and EMS. Our remaining operations, which represent non-core businesses, are reported in our Other operating segment. We are headquartered in Chandler, Arizona.

Our growth and profitability strategy is based upon the following principles: (1) market-driven organization, (2) innovation leadership, (3) synergistic mergers and acquisitions, and (4) operational excellence. Our priorities in executing this strategy are focused on driving near-term improvements to profitability and improving the growth outlook for the Company over the next several years by further strengthening our focus on commercial activities, expanding capacity to meet customer demand and driving innovation.

As a market-driven organization, we are focused on capitalizing on growth opportunities in the increasing electrification of vehicles, including EV/HEV, and increasing use of ADAS in the automotive industry, the advancement of communication systems in aerospace and defense, the growth of 5G smartphones in the portable electronics industry, and in renewable energy. In addition to our focus on these markets, we sell into a variety of other markets including general industrial, wireless infrastructure and mass transit.

Our growth strategy is based on addressing trends in these markets and applying our repeatable customer engagement process. Our sales engineers and technical service employees work closely with our customers to understand their complex challenges. They then leverage our innovation and technology capabilities and deep applications expertise to provide unique solutions to customers’ challenges. In addition to these capabilities, our strategy for success as a manufacturer of engineered materials and components is also built on our reputation for high performance and reliability solutions, trusted customer relationships, a broad product portfolio and custom design capabilities. Through this strategy we expect to be able to drive further commercial wins, which provide the potential for higher growth in the future. We have also expanded our capabilities through organic investment and acquisitions and strive to ensure high quality solutions for our customers.

Our operational excellence efforts are focused on driving significant near-term enhancements to our profitability and ongoing cost structure improvements. These efforts include focusing on improving yields, throughput, procurement capabilities and manufacturing processes and selectively adding strategic new hires to achieve better performance. We have also taken specific cost improvement actions in the fourth quarter of 2022 through the end of 2023 that have benefited subsequent quarters. These actions include optimizing our manufacturing footprint, divesting non-core product lines and reductions to manufacturing and corporate employees. We continue to review and re-align our manufacturing and engineering footprint in an effort to maintain a leading competitive position globally and to support our customers’ growth initiatives.

We seek to enhance our operational and financial performance by investing in research and development, manufacturing and materials efficiencies, and new product initiatives that respond to the needs of our customers. We strive to evaluate operational

24

and strategic alternatives to improve our business structure and align our business with the changing needs of our customers and major industry trends affecting our business.

If we are able to successfully execute on our strategy, we see an opportunity, over the next several years, to return to historical levels of profitability and meaningfully improve revenues from 2023 levels, led by organic growth and complemented by targeted acquisitions. This outlook is supported by our participation in a number of growth markets and by our strong competitive positions in these markets. The fastest growing market opportunity is expected to be EV/HEV where third-party analysis projects that the market will increase at a compound annual growth rate of between 15% and 20% over the next several years. Within the EV/HEV market, we believe our advanced battery cell pads, ceramic substrates and power interconnects provide multiple content opportunities to capitalize on this growth. Across these areas we have secured a number of design wins and have a strong opportunity pipeline, which provides confidence in our growth outlook. Other markets with a good growth trajectory include ADAS, aerospace and defense, portable electronics and renewable energy. Each of these markets is expected to contribute to our growth.

Executive Summary

The following key highlights and factors should be considered when reviewing our results of operations, financial position and liquidity:

•In the first quarter of 2024 as compared to the first quarter of 2023, our net sales decreased approximately 12.5% to $213.4 million, our gross margin decreased approximately 70 basis points to 32.0% from 32.7%, and we had an operating income of 5.5% compared to an operating loss of 0.1%, an increase of approximately 560 basis points.

•We made $30.0 million of discretionary principal payments on our revolving credit facility in the first quarter of 2024.

Results of Operations

The following table sets forth, for the periods indicated, selected operations data expressed as a percentage of net sales:

	Three Months Ended
	March 31, 2024		March 31, 2023
Net sales	100.0	%	100.0	%
Gross margin	32.0	%	32.7	%
Selling, general and administrative expenses	22.3	%	24.6	%
Research and development expenses	4.2	%	3.9	%
Restructuring and impairment charges	—	%	4.3	%
Other operating (income) expense, net	—	%	—	%
Operating income (loss)	5.5	%	(0.1)	%
Equity income in unconsolidated joint ventures	0.1	%	—	%
Other income (expense), net	0.2	%	—	%
Interest expense, net	(0.4)	%	(1.4)	%
Income (loss) before income taxes	5.4	%	(1.5)	%
Income tax expense (benefit)	1.8	%	(0.1)	%
Net income (loss)	3.7	%	(1.4)	%

Net Sales and Gross Margin
	Three Months Ended
(Dollars in millions)	March 31, 2024			March 31, 2023
Net sales	$	213.4		$	243.8
Gross margin	$	68.2		$	79.7
Percentage of net sales	32.0		%	32.7		%

Net sales decreased by 12.5% in the first quarter of 2024 compared to the first quarter of 2023. Our AES and EMS operating segments had net sales decreases of 10.2% and 16.1%, respectively. The decrease in net sales was primarily due to lower net sales in the EV/HEV, ADAS and renewable energy markets in our AES operating segment and lower net sales in the general industrial and consumer markets in our EMS operating segment. The decrease was partially offset by higher net sales in the wireless infrastructure and aerospace and defense markets in our AES operating segment and higher net sales in the EV/HEV

25

and aerospace and defense markets in our EMS operating segment. We experienced lower EV/HEV net sales in our AES operating segment as customers continued to manage inventory levels and adjusted to softer end market demand. Foreign currency exchange rate changes year-over-year had an immaterial impact on net sales on a quarter-to-date basis.

Gross margin as a percentage of net sales decreased approximately 70 basis points to 32.0% in the first quarter of 2024 compared to 32.7% in the first quarter of 2023. Gross margin in the first quarter of 2024 declined due to unfavorable impacts from lower volume and unfavorable mix in our AES and EMS operating segments, as well as unfavorable factory utilization in our AES operating segment. This was partially offset by lower raw material costs, favorable yield performance and lower inventory reserves provisions in our AES and EMS operating segments, as well as favorable impacts in factory utilization from our factory optimization efforts in our EMS operating segment.

Selling, General and Administrative Expenses
	Three Months Ended
(Dollars in millions)	March 31, 2024			March 31, 2023
Selling, general and administrative expenses	$	47.5		$	60.1
Percentage of net sales	22.3		%	24.6		%

SG&A expenses decreased 21.0% in the first quarter of 2024 from the first quarter of 2023, primarily due to a $9.9 million decrease in professional services expense, a $0.9 million decrease in total compensation and benefits and a $0.7 million decrease in recruiting, relocation and training expenses. The decrease in professional services expense was primarily attributable to the non-recurrence of the $7.6 million of non-routine shareholder advisory costs.

Research and Development Expenses
	Three Months Ended
(Dollars in millions)	March 31, 2024			March 31, 2023
Research and development expenses	$	8.9		$	9.6
Percentage of net sales	4.2		%	3.9		%

R&D expenses decreased 7.3% in the first quarter of 2024 from the first quarter of 2023 due to a $0.6 million decrease in professional services expense and a $0.4 million decrease in total compensation and benefits expense, partially offset by a $0.2 million increase in trial costs for alternative raw materials.

Restructuring and Impairment Charges and Other Operating (Income) Expense, Net
	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Restructuring and impairment charges	$	0.1	$	10.5
Other operating (income) expense, net	$	—	$	(0.2)

We incurred restructuring charges and related expenses in 2023 associated with the announced reduction of our global workforce along with certain facility consolidation efforts, which were substantially completed as of December 31, 2023. The plans significantly reduced our manufacturing costs and operating expenses. We recognized restructuring charges and related expenses pertaining to these restructuring projects of $10.5 million for the three months ended March 31, 2023. For additional information, refer to “Note 14 – Supplemental Financial Information” to the condensed consolidated financial statements in Part I, Item 1 of this Form 10-Q.

With respect to other operating (income) expense, net, we recognized no income and income of $0.2 million in the first quarter of 2024 and 2023, respectively. The impact in the first quarter of 2023 primarily consisted of insurance recoveries, partially offset by professional service costs, from the fire at our UTIS manufacturing facility in Ansan, South Korea. For additional information, refer to “Note 14 – Supplemental Financial Information” to the condensed consolidated financial statements in Part I, Item 1 of this Form 10-Q.

Equity Income in Unconsolidated Joint Ventures
	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Equity income in unconsolidated joint ventures	$	0.3	$	0.1

26

As of March 31, 2024, we had two unconsolidated joint ventures, each 50% owned: RIC and RIS. Equity income in those unconsolidated joint ventures increased $0.2 million in the first quarter of 2024 from the first quarter of 2023. On a quarter-to-date basis, the increase was due to higher net sales and lower SG&A costs for RIC. The higher net sales for RIC was primarily driven by the portable electronics market in Asia.

Other Income (Expense), Net
	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Other income (expense), net	$	0.4	$	0.1

Other income (expense), net increased to income of $0.4 million in the first quarter of 2024 from income of $0.1 million in the first quarter of 2023. The increase was due to favorable year-over-year change in impacts from our foreign currency transactions, partially offset by unfavorable year-over-year change in impacts from our foreign currency derivatives.

Interest Expense, Net
	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Interest expense, net	$	(0.8)	$	(3.5)

Interest expense, net, decreased by $2.7 million in the first quarter of 2024 from the first quarter of 2023. The decrease on a year-over-year quarter-to-date basis was primarily due to a lower weighted-average outstanding borrowings under our revolving credit facility.

Income Taxes
	Three Months Ended
(Dollars in millions)	March 31, 2024			March 31, 2023
Income tax expense (benefit)	$	3.8		$	(0.1)
Effective tax rate	32.8		%	3.5		%

The below discussion of the effective tax rate for the periods presented in the consolidated statements of operations is in comparison to the 21% U.S. statutory federal income tax rate.

Our effective tax rate was 32.8% in the first quarter of 2024. During the first quarter of 2024, our effective tax rate was unfavorably impacted primarily by the write-off of deferred tax assets related to stock compensation.

During the first quarter of 2023, our effective tax rate was 3.5%. During the first quarter of 2023, our effective tax rate was unfavorably impacted primarily by an increase in the valuation allowance attributable to loss jurisdictions in which no benefit is anticipated to be realized.

Operating Segment Net Sales and Operating Income

Advanced Electronics Solutions

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Net sales	$	122.1	$	135.9
Operating income (loss)	$	4.4	$	(5.5)

AES net sales decreased by 10.2% in the first quarter of 2024 compared to the first quarter of 2023. The decrease in net sales over the first quarter of 2023 was primarily driven by lower net sales in the EV/HEV, ADAS and renewable energy markets, partially offset by higher net sales in the wireless infrastructure and aerospace and defense markets. We experienced lower EV/HEV net sales as customers continued to manage inventory levels and adjusted to softer end market demand. Foreign currency exchange rate changes year-over-year had an immaterial impact on net sales on a quarter-to-date basis.

We recognized operating income of $4.4 million in the first quarter of 2024 compared to an operating loss of $5.5 million in the first quarter of 2023. The increase in operating income was due to lower raw material costs, favorable yield performance and lower inventory reserves provisions, partially offset by the unfavorable impacts from lower volume and unfavorable mix, as well as unfavorable factory utilization. As a percentage of net sales, the operating income in the first quarter of 2024 was 3.6% compared to an operating loss of 4.1% reported in the first quarter of 2023.

27

Elastomeric Material Solutions

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Net sales	$	85.7	$	102.2
Operating income (loss)	$	5.3	$	3.2

EMS net sales decreased by 16.1% in the first quarter of 2024 compared to the first quarter of 2023. The decrease in net sales over the first quarter of 2023 was primarily driven by lower net sales in the general industrial and consumer markets, partially offset by higher net sales in the EV/HEV and aerospace and defense markets. Foreign currency exchange rate changes year-over-year had an immaterial impact on net sales on a quarter-to-date basis.

We recognized operating income of $5.3 million in the first quarter of 2024 compared to operating income of $3.2 million in the first quarter of 2023. The increase in operating income was due to lower raw material costs, favorable yield performance and lower inventory reserves provisions, as well as favorable impacts in factory utilization from our factory optimization efforts, partially offset by the unfavorable impacts from lower volume and unfavorable mix. As a percentage of net sales, operating income in the first quarter of 2024 was 6.2% compared to an operating income of 3.1% reported in the first quarter of 2023.

Other

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Net sales	$	5.6	$	5.7
Operating income (loss)	$	2.0	$	2.0

Net sales in this segment decreased by 1.8% in the first quarter of 2024 from the first quarter of 2023. Operating income was flat in the first quarter of 2024 compared to the first quarter of 2023. Operating income was primarily driven by unfavorable factory utilization offset by higher volume. As a percentage of net sales, the operating income in the first quarter of 2024 was 35.7% compared to an operating income of 35.1% reported in the first quarter of 2023.

Liquidity, Capital Resources and Financial Position

We believe that our existing sources of liquidity and cash flows that we expect to generate from our operations, together with our available credit facilities, will be sufficient to fund our operations, currently planned capital expenditures, research and development efforts and our debt service commitments, for at least the next 12 months. We regularly review and evaluate the adequacy of our cash flows, borrowing facilities and banking relationships in an effort to ensure that we have the appropriate access to cash to fund both our near-term operating needs and our long-term strategic initiatives.

The following table illustrates the location of our cash and cash equivalents by our three major geographic areas:

(Dollars in millions)	March 31, 2024		December 31, 2023
United States	$	52.2	$	60.0
Europe	34.5		37.6
Asia	30.2		34.1
Total cash and cash equivalents	$	116.9	$	131.7

Approximately $64.7 million of our cash and cash equivalents were held by non-U.S. subsidiaries as of March 31, 2024. We did not make any changes in the three months ended March 31, 2024 to our position on the permanent reinvestment of our earnings from foreign operations. With the exception of certain of our Chinese subsidiaries, where a substantial portion of our Asia cash and cash equivalents are held, we continue to assert that historical foreign earnings are indefinitely reinvested.

(Dollars in millions)	March 31, 2024		December 31, 2023
Key Financial Position Accounts:
Cash and cash equivalents	$	116.9	$	131.7
Accounts receivable, net	$	159.2	$	161.9
Inventories, net	$	150.9	$	153.5
Borrowings under revolving credit facility	$	—	$	30.0

28

Changes in key financial position accounts and other significant changes in our statements of financial position from December 31, 2023 to March 31, 2024 were as follows:

•Cash and cash equivalents were $116.9 million as compared to $131.7 million as of December 31, 2023, a decrease of $14.8 million, or 11.2%. This decrease was primarily due to $30.0 million in discretionary principal payments on our revolving credit facility, $9.4 million in capital expenditures and $1.1 million in tax payments related to net share settlement of equity awards, partially offset by cash flows provided by operations.

•Accounts receivable, net decreased 1.7% to $159.2 million as of March 31, 2024 from $161.9 million as of December 31, 2023. The decrease from year-end was primarily due to a $4.1 million receipt of previously recognized UTIS fire insurance receivables for our business interruption claims, a $1.0 million decrease in our income taxes receivable, partially offset by increases in our receivables due to a higher days sales outstanding at the end of March 31, 2024 compared to December 31, 2023.

•Inventories, net decreased 1.7% to $150.9 million as of March 31, 2024, from $153.5 million as of December 31, 2023, primarily driven by decrease in work-in-process and finished good levels partially offset by higher raw materials.

•Borrowings under revolving credit facility were nil as of March 31, 2024 compared to $30.0 million as of December 31, 2023. This decrease was due to $30.0 million in discretionary principal payments on our revolving credit facility made in the first three months of 2024. For additional information regarding this facility and the Fifth Amended Credit Agreement, refer to “Note 9 – Debt” to the condensed consolidated financial statements in Part I, Item 1 of this Form 10-Q.

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Key Cash Flow Measures:
Net cash provided by operating activities	$	28.1	$	1.8
Net cash used in investing activities	$	(9.4)	$	(15.4)
Net cash used in financing activities	$	(31.5)	$	(29.4)

In 2024, we expect capital spending to be in the range of approximately $60.0 million to $70.0 million. We plan to fund our capital spending in 2024 with cash from operations and cash on-hand, as well as our existing revolving credit facility, if necessary.

Restrictions on Payment of Dividends

The Fifth Amended Credit Agreement generally permits us to pay cash dividends to our shareholders, provided that (i) no default or event of default has occurred and is continuing or would result from the dividend payment and (ii) our total net leverage ratio does not exceed 2.75 to 1.00. If our total net leverage ratio exceeds 2.75 to 1.00, we may nonetheless make up to $20.0 million in restricted payments, including cash dividends, during the fiscal year, provided that no default or event of default has occurred and is continuing or would result from the payments. Our total net leverage ratio did not exceed 2.75 to 1.00 as of March 31, 2024.

Contingencies

During the first quarter of 2024, we did not become aware of any material developments related to environmental matters disclosed in our Annual Report, our asbestos litigation or other material contingencies previously disclosed or incur any material costs or capital expenditures related to such matters. Refer to “Note 10 – Commitments and Contingencies” to the condensed consolidated financial statements in Part I, Item 1 of this Form 10-Q for further discussion of these contingencies.

Critical Accounting Policies

There were no material changes in our critical accounting policies during the first quarter of 2024.

Item 3.    Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes in our exposure to market risk during the first quarter of 2024. For discussion of our exposure to market risk, refer to “Item 7A. Quantitative and Qualitative Disclosures About Market Risk” contained in our Annual Report.

29

Item 4.    Controls and Procedures

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

We conducted, with the participation of our Chief Executive Officer and Chief Financial Officer, an evaluation of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d- 15(e) under the Exchange Act, as of March 31, 2024. Our disclosure controls and procedures are designed (i) to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Based on their evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of March 31, 2024.

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

There were no changes in the Company’s internal control over financial reporting during the first quarter of the fiscal year ended December 31, 2024, that have materially affected or are reasonably likely to materially affect the Company’s internal control over financial reporting, as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act.

30

Part II - Other Information

Item 1.    Legal Proceedings

Refer to the discussion of certain environmental, asbestos and other litigation matters in “Note 10 – Commitments and Contingencies” to the condensed consolidated financial statements in Part I, Item 1 of this Form 10-Q.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Items 2 (a) and (b) are not applicable.

(c) Stock Repurchases

(Dollars in millions, except shares and per share amounts)
Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet be Purchased under the Plans or Programs
March 1, 2024 to March 31, 2024	1,500	$	109.92	1,500	$	23.8

During the quarter ended March 31, 2024, we repurchased 1,500 shares of our capital stock for $0.2 million under a $100.0 million share repurchase program approved by our Board of Directors in 2015. The share repurchase program has no expiration date and may be suspended or discontinued at any time without notice. As of March 31, 2024, $23.8 million remained for repurchase under the share repurchase program. All repurchases were made using cash from operations. Our stock repurchases may occur from time to time through open market purchases, privately negotiated transactions or plans designed to comply with Rule 10b5-1 promulgated under the Exchange Act.

Item 5. Other Information

During the three months ended March 31, 2024, none of our directors or officers adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement”, as each term is defined in Item 408 of Regulation S-K.

31

Item 6.    Exhibits

List of Exhibits:
10.1	Form of Performance-Based Restricted Stock Unit Award Agreement (Net Revenue), incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K filed on February 23, 2024
10.2	Offer letter between the Registrant and Larry Schmid, accepted and agreed to be effective as of January 11, 2023.
10.3	Offer letter between the Registrant and Jessica Morton, accepted and agreed to be effective as of February 13, 2023.
10.4	Offer letter between the Registrant and Michael Reed Webb, accepted and agreed to be effective as of April 7, 2023.
31.1	Certification of President and Chief Executive Officer (Principal Executive Officer) pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.
31.2	Certification of Senior Vice President and Chief Financial Officer (Principal Financial Officer) pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.
32	Certification of President and Chief Executive Officer (Principal Executive Officer) and Senior Vice President and Chief Financial Officer (Principal Financial Officer) pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, furnished herewith.
101	The following materials from Rogers Corporation’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 formatted in iXBRL (Inline Extensible Business Reporting Language): (i) Condensed Consolidated Statements of Operations for the three months ended March 31, 2024 and March 31, 2023, (ii) Condensed Consolidated Statements of Comprehensive Income (Loss) for the three months ended March 31, 2024 and March 31, 2023, (iii) Condensed Consolidated Statements of Financial Position as of March 31, 2024 and December 31, 2023, (iv) Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2024 and March 31, 2023, (v) Condensed Consolidated Statements of Shareholders’ Equity for the three months ended March 31, 2024 and March 31, 2023, (vi) Notes to Condensed Consolidated Financial Statements and (vii) Cover Page.
104	The cover page from Rogers Corporation’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024, formatted in iXBRL and contained in Exhibit 101.

32

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

ROGERS CORPORATION
(Registrant)

/s/ Ramakumar Mayampurath

Ramakumar Mayampurath

Senior Vice President, Chief Financial Officer and Treasurer

Principal Financial Officer

Dated: April 25, 2024

33

EX-10.2

Exhibit 10.2

2225 W. Chandler Boulevard | Chandler, AZ 85296 | 480.917.6000

January 10, 2023

Larry Schmid

Dear Larry,

It is a pleasure to confirm Rogers' offer of employment to you for the position of Senior Vice President of Global Operations (subject to the conditions described below). Rogers does not enter employment contracts, and your employment will be “at will.” Below is a general description of the terms we expect to apply to your employment:

Your employment is expected to commence on before (To Be Determined).

The compensation package for this position is as follows and is subject to the usual payroll deductions such as income tax and Social Security:

•Your starting salary will be $420,000 USD per year, which is paid at a bi-weekly rate of $16,154 USD. This is an exempt position, which means that your salary is intended to compensate you for all hours worked, and you will not be eligible to receive overtime pay.

•You will be eligible for four weeks of vacation effective from your first day of employment.

•Effective for the 2023 fiscal year, you are eligible for an award under the Annual Incentive Compensation Plan (AICP) with a target of 55% of your base salary. Depending on actual performance against predetermined company performance metrics, your actual AICP award payout can be as high as 200% of your target incentive. Actual awards are prorated according to date of hire. Awards are subject to the terms of the AICP and approval by the Compensation and Organization Committee (the “Committee”).

•You will be eligible for an annual long-term incentive grant with a 2023 target of 175% of your base salary, currently valued at approximately $735,000 USD. The annual grant will be comprised of:

o50% Time-Based Restricted Stock Units — (three-year ratable vesting)

o50% Performance-Based Restricted Stock Units — (three-year performance period)

The grant value and subsequent number of shares or units you would receive are determined annually and presented to the Board of Directors' Compensation Committee for review and approval, except that your 2023 award will be granted as of your date of hire (rather than as part of the Company's annual grant process), and the total number of stock units for the 2023 award will be determined by dividing the initial grant value specified above by the average closing stock price for the 30 days prior to your date of hire. The terms of these awards are subject to the applicable award agreements and plan document.

You will be eligible for the retirement, health and other benefit programs provided to executives of Rogers, subject to the right of Rogers to amend or terminate such programs in accordance with their terms. You will also be eligible to participate in the Rogers Corporation Severance Plan, provided that, in the event of a Qualifying Termination of employment within the 24-month period following your date of hire, (a) your “Severance Coverage Period” under

such plan shall be 18 months, and (b) 50% of your unvested equity awards shall vest immediately. For the avoidance of doubt, the Company reserves the right to modify these benefits to conform to any severance plan covering executives.

As a condition of employment, you must sign the enclosed agreement regarding confidentiality of trade secrets and confidential business information (Employment, Invention, Confidentiality and Non-Compete Agreement). Please review this agreement. You will need to sign it and deliver it to Lori Gaudet, Human Resources Director, at the time you start work with Rogers.

As mentioned above, your employment is “at will,” meaning that either you or Rogers may terminate your employment at any time and for any reason, with or without cause or notice, regardless of any representations that may have been made to you. This offer letter does not establish a contractual employment relationship. It is Rogers' policy not to enter into employment contracts.

Our offer is contingent upon a satisfactory reference check and satisfactory results of a background check.

For purposes of US immigration law, you will be required to provide to Rogers documentary evidence of your identity and eligibility for employment in the United States. Such documentation must be provided within three (3) business days of your date of hire.

I look forward to having you join Rogers and working together.

Sincerely,

Colin Gouveia
President and Chief Executive Officer /s/ Larry Schmid Offer Accepted by Larry Schmid January 11, 2023            
Date

CC:
Lori Gaudet

Human Resources Director

EX-10.3

Exhibit 10.3

2225 W. Chandler Boulevard | Chandler, AZ 85296 | 480.917.6000

January 30, 2023

Jessica Morton

Dear Jessica,

It is a pleasure to confirm Rogers’ offer of employment to you for the position of Vice President, General Counsel and Corporate Secretary (subject to the conditions described below). Rogers does not enter employment contracts, and your employment will be “at will.” Below is a general description of the terms we expect to apply to your employment:

Your employment is expected to commence on or before (To Be Determined).

The compensation package for this position is as follows and is subject to the usual payroll deductions such as income tax and Social Security:

•Your starting salary will be $430,000 USD per year, which is paid at a bi-weekly rate of $16,538.47 USD. This is an exempt position, which means that your salary is intended to compensate you for all hours worked, and you will not be eligible to receive overtime pay.

•You will be eligible for four weeks of vacation effective from your first day of employment.

•Effective for the 2023 fiscal year, you are eligible for an award under the Annual Incentive Compensation Plan (AICP) with a target of 55% of your base salary. Depending on actual performance against predetermined company performance metrics, your actual AICP award payout can be as high as 200% of your target incentive. Actual awards are prorated according to date of hire. Awards are subject to the terms of the AICP and approval by the Compensation and Organization Committee (the “Committee”).

•You will be eligible for an annual long-term incentive grant with a 2023 target of 160% of your base salary, currently valued at approximately $688,000 USD. The annual grant will be comprised of:

o50% Time-Based Restricted Stock Units — (three-year ratable vesting)

o50% Performance-Based Restricted Stock Units — (three-year performance period)

The grant value and subsequent number of shares or units you would receive are determined annually and presented to the Board of Directors’ Compensation Committee for review and approval, except that your 2023 award will be granted as of your date of hire (rather than as part of the Company's annual grant process), and the total number of stock units for the 2023 award will be determined by dividing the initial grant value specified above by the average closing stock price for the 30 days prior to your date of hire. The terms of these awards are subject to the applicable award agreements and plan document.

•You will receive a one-time sign on bonus of $300,000 USD, which will be payable in your first paycheck. If you voluntarily resign from Rogers or are terminated for cause within one year of the payment of the said bonus, you will be required to reimburse the Company for the full amount of the

bonus. This letter authorizes Rogers to deduct monies from your final paycheck. Any remaining amount must be paid within 30 days of your last day of work.

You will be eligible for the retirement, health and other benefit programs provided to executives of Rogers, subject to the right of Rogers to amend or terminate such programs in accordance with their terms. You will also be eligible to participate in the Rogers Corporation Severance Plan, provided that, in the event of a Qualifying Termination of employment within the 24-month period following your date of hire, (a) your “Severance Coverage Period” under such plan shall be 18 months, and (b) 50% of your unvested equity awards shall vest immediately. For the avoidance of doubt, the Company reserves the right to modify these benefits to conform to any severance plan covering executives.

As a condition of employment, you must sign the enclosed agreement regarding confidentiality of trade secrets and confidential business information (Employment, Invention, Confidentiality and Non-Compete Agreement). Please review this agreement. You will need to sign it and deliver it to Lori Gaudet, Human Resources Director, at the time you start work with Rogers.

As mentioned above, your employment is “at will,” meaning that either you or Rogers may terminate your employment at any time and for any reason, with or without cause or notice, regardless of any representations that may have been made to you. This offer letter does not establish a contractual employment relationship. It is Rogers' policy not to enter into employment contracts.

Our offer is contingent upon a satisfactory reference check and satisfactory results of a background check.

For purposes of US immigration law, you will be required to provide to Rogers documentary evidence of your identity and eligibility for employment in the United States. Such documentation must be provided within three (3) business days of your date of hire.

******

Those of us who met you during the interview process were very impressed with your qualifications, accomplishments and capabilities. We believe that you are a very good fit for the Growth Team and are optimistic you will accept our offer. Rogers should provide you many interesting and diverse opportunities to learn and grow.

We look forward to hearing from you and welcoming you to the team. If you have any questions regarding our employment offer, or Rogers in general, please do not hesitate to contact me at 302-898-1098. Thank you.

Sincerely,

Colin Gouveia
President and Chief Executive Officer  /s/ Jessica Morton Offer Accepted by Jessica Morton February 13, 2023            
Date

CC:
Lori Gaudet

Human Resources Director

EX-10.4

Exhibit 10.4

2225 W. Chandler Boulevard | Chandler, AZ 85296 | 480.917.6000

April 6, 2023

Michael Reed Webb

Dear Michael,

It is a pleasure to confirm Rogers’ offer of employment to you for the position of Sr. Vice President, Chief Administrative Officer (subject to the conditions described below). Rogers does not enter employment contracts, and your employment will be “at will.” Below is a general description of the terms we expect to apply to your employment:

Your employment is expected to commence on April 11, 2023.

The compensation package for this position is as follows and is subject to the usual payroll deductions such as income tax and Social Security:

•Your starting salary will be $450,000 USD per year, which is paid at a bi-weekly rate of $17,307.70 USD. This is an exempt position, which means that your salary is intended to compensate you for all hours worked, and you will not be eligible to receive overtime pay.

•You will be eligible for four weeks of vacation effective from your first day of employment.

•Effective for the 2023 fiscal year, you are eligible for an award under the Annual Incentive Compensation Plan (AICP) with a target of 70% of your base salary. Depending on actual performance against predetermined company performance metrics, your actual AICP award payout can be as high as 200% of your target incentive. Actual awards are prorated according to date of hire. Awards are subject to the terms of the AICP and approval by the Compensation and Organization Committee (the “Committee”).

•You will be eligible for an annual long-term incentive grant with a 2023 target of 150% of your base salary, currently valued at approximately $675,000 USD. The annual grant will be comprised of:

o50% Time-Based Restricted Stock Units — (three-year ratable vesting)

o50% Performance-Based Restricted Stock Units — (three-year performance period)

The grant value and subsequent number of shares or units you would receive are determined annually and presented to the Board of Directors’ Compensation Committee for review and approval, except that your 2023 award will be granted as of your date of hire (rather than as part of the Company’s annual grant process), and the total number of stock units for the 2023 award will be determined by dividing the initial grant value specified above by the average closing stock price for the 30 days prior to your date of hire. The terms of these awards are subject to the applicable award agreements and plan document.

Upon your relocation to the Phoenix, Arizona area, you will be eligible for the retirement, health and other benefit programs provided to executives of Rogers, subject to the right of Rogers to amend or terminate such programs in accordance with their terms. Prior to your relocation, in lieu of such benefits, Rogers will pay you a stipend of $43,000 payable in your first paycheck. You will immediately be eligible to participate in the Rogers Corporation

Severance Plan. For the avoidance of doubt, the Company reserves the right to modify these benefits to conform to any severance plan covering executives.

During the period of time that you are a resident of Canada, you will be subject to certain limitations and restrictions, in accordance with company policy, which must be observed. During this period, you will have no authority, nor shall you hold yourself out as having authority, to execute or conclude any contract or agreement on behalf of Rogers or any of its subsidiaries. Further, during this period Rogers will not provide you with an office in Canada nor will it reimburse you for any expense associated with any office you may choose to maintain for purposes of performing the functions of your job.

As part of your acceptance of this offer, you agree to relocate your residence to the Phoenix, Arizona area by no later than August 31, 2024, and to use your best efforts to relocate to the Phoenix area within one year of your start date. You will be provided with relocation benefits as described in the Relocation Policy, which will be sent to you separately. Please contact Lori Gaudet, Human Resources Director, to begin the relocation process. If you voluntarily resign from Rogers within one year of your relocation, you will be required to reimburse all monies paid under the Relocation Policy directly to you, or on your behalf. This letter authorizes Rogers to deduct any required reimbursement from your final paycheck or other post-employment compensation (to the extent permitted by law). You must arrange for repayment in full to Rogers of any remaining amount, with such repayment to be made within 30 days of your last day of work.

As a condition of employment, you must sign the enclosed agreement regarding confidentiality of trade secrets and confidential business information (Employment, Invention, Confidentiality and Non-Compete Agreement). Please review this agreement. You will need to sign it and deliver it to Lori Gaudet, Human Resources Director, at the time you start work with Rogers.

As mentioned above, your employment is “at will,” meaning that either you or Rogers may terminate your employment at any time and for any reason, with or without cause or notice, regardless of any representations that may have been made to you. This offer letter does not establish a contractual employment relationship. It is Rogers’ policy not to enter into employment contracts.

Our offer is contingent upon a satisfactory reference check and satisfactory results of a background check.

For purposes of US immigration law, you will be required to provide to Rogers documentary evidence of your identity and eligibility for employment in the United States. Such documentation must be provided within three (3) business days of your date of hire.

I look forward to having you join Rogers and working together.

Sincerely,

Colin Gouveia
President and Chief Executive Officer  /s/ Michael Reed Webb Offer Accepted by Michael Reed Webb April 7, 2023            
Date

CC:
Lori Gaudet

Human Resources Director

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, R. Colin Gouveia, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Rogers Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: April 25, 2024

/s/ R. Colin Gouveia

R. Colin Gouveia

President and Chief Executive Officer
Principal Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Ramakumar Mayampurath, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Rogers Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Dated: April 25, 2024

/s/ Ramakumar Mayampurath

Ramakumar Mayampurath

Senior Vice President, Chief Financial Officer and Treasurer
Principal Financial Officer

EX-32

Exhibit 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of Rogers Corporation, a Massachusetts corporation (the “Corporation”), does hereby certify that:

The Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the “Form 10-Q”) of the Corporation fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Corporation.

/s/ R. Colin Gouveia

R. Colin Gouveia

President and Chief Executive Officer
Principal Executive Officer

April 25, 2024

/s/ Ramakumar Mayampurath

Ramakumar Mayampurath

Senior Vice President, Chief Financial Officer and Treasurer

Principal Financial Officer

April 25, 2024

XML

Cover - shares	3 Months Ended
	Mar. 31, 2024	Apr. 22, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	1-4347
Entity Registrant Name	ROGERS CORP
Entity Incorporation, State or Country Code	MA
Entity Tax Identification Number	06-0513860
Entity Address, Address Line One	2225 W. Chandler Blvd.
Entity Address, City or Town	Chandler
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85224-6155
City Area Code	480
Local Phone Number	917-6000
Title of 12(b) Security	Capital Stock,
Entity Trading Symbol	ROG
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		18,656,607
Entity Central Index Key	0000084748
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Amendment Flag	false

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands, shares in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net sales	$ 213,400	$ 243,800
Cost of sales	145,200	164,100
Gross margin	68,200	79,700
Selling, general and administrative expenses	47,500	60,100
Research and development expenses	8,900	9,600
Restructuring and impairment charges	100	10,500
Other operating (income) expense, net	0	(200)
Operating income (loss)	11,700	(300)
Equity income in unconsolidated joint ventures	300	100
Other income (expense), net	400	100
Interest expense, net	(800)	(3,500)
Income (loss) before income taxes	11,600	(3,600)
Income tax expense (benefit)	3,800	(100)
Net income (loss)	$ 7,800	$ (3,500)
Basic earnings per share (in dollars per share)	$ 0.42	$ (0.19)
Diluted earnings per share (in dollars per share)	$ 0.42	$ (0.19)
Shares used in computing:
Basic earnings per share (in shares)	18.6	18.6
Diluted earnings per share (in shares)	18.7	18.6

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 7.8	$ (3.5)
Foreign currency translation adjustment	(9.2)	9.7
Pension and other postretirement benefits:
Amortization of loss, net of tax (Note 2)	0.1	0.0
Other comprehensive income (loss)	(9.1)	9.7
Comprehensive income (loss)	$ (1.3)	$ 6.2

XML

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 116.9	$ 131.7
Accounts receivable, less allowance for credit losses of $1.0 and $1.1	159.2	161.9
Contract assets	40.3	45.2
Inventories, net	150.9	153.5
Asbestos-related insurance receivables, current portion	4.3	4.3
Other current assets	29.8	30.3
Total current assets	501.4	526.9
Property, plant and equipment, net of accumulated depreciation of $386.2 and $385.7	363.4	366.3
Operating lease right-of-use assets	18.6	18.9
Goodwill	357.2	359.8
Other intangible assets, net of amortization	120.3	123.9
Asbestos-related insurance receivables, non-current portion	52.2	52.2
Investments in unconsolidated joint ventures	10.9	11.1
Deferred income taxes	55.7	49.7
Other long-term assets	8.3	8.4
Total assets	1,488.0	1,517.2
Current liabilities
Accounts payable	51.7	50.3
Accrued employee benefits and compensation	29.5	31.1
Accrued income taxes payable	7.3	2.0
Operating lease obligations, current portion	3.8	3.5
Asbestos-related liabilities, current portion	$ 5.5	$ 5.5
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Other accrued liabilities	Other accrued liabilities
Other accrued liabilities	$ 19.2	$ 24.0
Total current liabilities	117.0	116.4
Borrowings under revolving credit facility	0.0	30.0
Operating lease obligations, non-current portion	15.1	15.4
Asbestos-related liabilities, non-current portion	56.0	56.0
Non-current income tax	7.2	7.2
Deferred income taxes	22.7	22.9
Other long-term liabilities	10.2	10.3
Commitments and contingencies (Note 6 and Note 10)
Shareholders’ equity
Capital stock - $1 par value; 50.0 authorized shares; 18.7 and 18.6 shares issued and outstanding	18.7	18.6
Additional paid-in capital	153.8	151.8
Retained earnings	1,162.8	1,155.0
Accumulated other comprehensive loss	(75.5)	(66.4)
Total shareholders' equity	1,259.8	1,259.0
Total liabilities and shareholders' equity	$ 1,488.0	$ 1,517.2

XML

CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Parenthetical) - USD ($) shares in Millions, $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 1.0	$ 1.1
Property, plant and equipment, accumulated depreciation	$ 386.2	$ 385.7
Capital Stock, par value (in dollars per share)	$ 1	$ 1
Capital Stock, authorized shares (in shares)	50.0	50.0
Capital Stock, shares issued (in shares)	18.7	18.6
Capital Stock, shares outstanding (in shares)	18.7	18.6

XML

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Millions	Total	Capital Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Loss
Balance, beginning of period at Dec. 31, 2022		$ 18.6	$ 140.7	$ 1,098.4	$ (85.2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued for vested restricted stock units, net of shares withheld for taxes		0.0	(2.5)
Shares repurchased		0.0	0.0
Equity compensation expense			2.1
Net income (loss)	$ (3.5)			(3.5)
Other comprehensive income (loss)	9.7				9.7
Balance, end of period at Mar. 31, 2023	1,178.3	18.6	140.3	1,094.9	(75.5)
Balance, beginning of period at Dec. 31, 2023	1,259.0	18.6	151.8	1,155.0	(66.4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued for vested restricted stock units, net of shares withheld for taxes		0.1	(1.2)
Shares repurchased	(0.2)	0.0	(0.3)
Equity compensation expense			3.5
Net income (loss)	7.8			7.8
Other comprehensive income (loss)	(9.1)				(9.1)
Balance, end of period at Mar. 31, 2024	$ 1,259.8	$ 18.7	$ 153.8	$ 1,162.8	$ (75.5)

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating Activities:
Net income (loss)	$ 7.8	$ (3.5)
Adjustments to reconcile net income (loss) to cash provided by operating activities:
Depreciation and amortization	11.3	14.6
Equity compensation expense	3.5	2.1
Deferred income taxes	(5.9)	(7.4)
Equity in undistributed income of unconsolidated joint ventures	(0.3)	(0.1)
Dividends received from unconsolidated joint ventures	1.2	1.5
Other non-cash charges, net	0.1	0.1
Changes in assets and liabilities:
Accounts receivable	(2.8)	2.6
Proceeds from insurance related to operations	4.1	0.5
Contract assets	4.1	(7.9)
Inventories, net	1.3	3.9
Other current assets	0.4	5.4
Accounts payable and other accrued expenses	2.0	(8.8)
Other, net	1.3	(1.2)
Net cash provided by operating activities	28.1	1.8
Investing Activities:
Capital expenditures	(9.4)	(16.4)
Disposition of business	0.0	1.0
Net cash used in investing activities	(9.4)	(15.4)
Financing Activities:
Repayment of debt principal and finance lease obligations	(30.1)	(25.1)
Line of credit issuance costs	0.0	(1.8)
Payments of taxes related to net share settlement of equity awards	(1.1)	(2.5)
Share repurchases	(0.3)	0.0
Net cash used in financing activities	(31.5)	(29.4)
Effect of exchange rate fluctuations on cash	(2.0)	0.8
Net decrease in cash and cash equivalents	(14.8)	(42.2)
Cash and cash equivalents at beginning of period	131.7	235.9
Cash and cash equivalents at end of period	116.9	193.7
Supplemental Disclosures:
Accrued capital additions	5.4	2.1
Interest, net of amounts capitalized	0.5	3.5
Income taxes, net of refunds	$ 3.1	$ 4.0

XML

Basis of Presentation

3 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Basis of Presentation

As used herein, the terms “Company,” “Rogers,” “we,” “us,” “our” and similar terms mean Rogers Corporation and its consolidated subsidiaries, unless the context indicates otherwise.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with GAAP for interim financial information. Accordingly, these statements do not include all of the information and footnotes required by GAAP for complete financial statements. In our opinion, the accompanying condensed consolidated financial statements include all normal recurring adjustments necessary for their fair presentation in accordance with GAAP. All significant intercompany balances and transactions have been eliminated.

Interim results are not necessarily indicative of results for a full year. For further information regarding our accounting policies, refer to the audited consolidated financial statements and footnotes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2023.

XML

Accumulated Other Comprehensive Loss

3 Months Ended

Mar. 31, 2024

Equity [Abstract]

Accumulated Other Comprehensive Loss

Accumulated Other Comprehensive Loss

The changes in accumulated other comprehensive loss by component were as follows:

(Dollars and accompanying footnotes in millions)	Foreign Currency Translation Adjustments		Pension and Other Postretirement Benefits(1)		Total
Balance as of December 31, 2023	$	(56.8)	$	(9.6)	$	(66.4)
Other comprehensive income (loss) before reclassifications	(9.2)		—		(9.2)
Amounts reclassified from accumulated other comprehensive loss	—		0.1		0.1
Net current-period other comprehensive income (loss)	(9.2)		0.1		(9.1)
Balance as of March 31, 2024	$	(66.0)	$	(9.5)	$	(75.5)
Balance as of December 31, 2022	$	(75.6)	$	(9.6)	$	(85.2)
Other comprehensive income (loss) before reclassifications	9.7		—		9.7
Amounts reclassified from accumulated other comprehensive loss	—		—		—
Net current-period other comprehensive income (loss)	9.7		—		9.7
Balance as of March 31, 2023	$	(65.9)	$	(9.6)	$	(75.5)

(1) Net of taxes of $1.8 million for both March 31, 2024 and December 31, 2023. Net of taxes of $1.9 million for both March 31, 2023 and December 31, 2022.

XML

Derivatives and Hedging

3 Months Ended

Mar. 31, 2024

Fair Value Disclosures [Abstract]

Derivatives and Hedging

Derivatives and Hedging

The valuation of our derivative contracts used to manage their respective risks is described below:

•Foreign Currency – The fair value of any foreign currency option derivative is based upon valuation models applied to current market information such as strike price, spot rate, maturity date and volatility, and by reference to market values resulting from an over-the-counter market or obtaining market data for similar instruments with similar characteristics.

•Commodity – The fair value of copper derivatives is computed using a combination of intrinsic and time value valuation models, which are collectively a function of five primary variables: price of the underlying instrument, time to expiration, strike price, interest rate and volatility. The intrinsic valuation model reflects the difference between the strike price of the underlying copper derivative instrument and the current prevailing copper prices in an over-the-counter market at period end. The time value valuation model incorporates changes in the price of the underlying copper derivative instrument, the time value of money, the underlying copper derivative instrument’s strike price and the remaining time to the underlying copper derivative instrument’s expiration date from the period end date.

As of March 31, 2024, we did not have any derivative contracts that qualified for hedge accounting treatment.

Foreign Currency

During the three months ended March 31, 2024, we entered into U.S. dollar, euro, Korean won, and Japanese yen forward contracts. We entered into these foreign currency forward contracts to mitigate certain global transactional exposures. These contracts do not qualify for hedge accounting treatment. As a result, any fair value adjustments required on these contracts are recorded in “Other income (expense), net” in our condensed consolidated statements of operations in the period in which the adjustment occurred.

As of March 31, 2024, the notional values of the remaining foreign currency forward contracts were as follows:

Notional Values of Foreign Currency Derivatives
USD/CNH	$	20,700,000
EUR/USD	€	14,700,000
KRW/USD	₩	5,372,800,000
JPY/EUR	¥	250,000,000

Commodity

As of March 31, 2024, we had 12 outstanding contracts to hedge exposure related to the purchase of copper in our AES operating segment. These contracts are held with financial institutions and are intended to offset rising copper prices and do not qualify for hedge accounting treatment. As a result, any fair value adjustments required on these contracts are recorded in “Other income (expense), net” in our condensed consolidated statements of operations in the period in which the adjustment occurred.

As of March 31, 2024, the volume of our copper contracts outstanding was as follows:

Volume of Copper Derivatives
April 2024 - June 2024	69 metric tons per month
July 2024 - September 2024	69 metric tons per month
October 2024 - December 2024	69 metric tons per month
January 2025 - March 2025	69 metric tons per month

Effects on Financial Statements

The impacts from our derivative instruments on the statement of operations and statements of comprehensive income were as follows:

		Three Months Ended
(Dollars in millions)	Financial Statement Line Item	March 31, 2024		March 31, 2023
Foreign Currency Contracts
Contracts not designated as hedging instruments	Other income (expense), net	$	(0.1)	$	—
Copper Derivative Contracts
Contracts not designated as hedging instruments	Other income (expense), net	$	—	$	—

The accounting guidance for fair value measurements establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value:

•Level 1 – Quoted prices in active markets for identical assets or liabilities.

•Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

•Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The fair values of derivative instruments measured at fair value on a recurring basis, categorized by contract type and level of inputs used in the valuation, were as follows:

	Derivative Instruments at Fair Value as of March 31, 2024
(Dollars in millions)	Level 1		Level 2		Level 3		Total(1)
Foreign currency contracts	$	—	$	(0.1)	$	—	$	(0.1)
Copper derivative contracts	$	—	$	0.5	$	—	$	0.5

	Derivative Instruments at Fair Value as of December 31, 2023
(Dollars in millions)	Level 1		Level 2		Level 3		Total(1)
Foreign currency contracts	$	—	$	(0.2)	$	—	$	(0.2)
Copper derivative contracts	$	—	$	0.4	$	—	$	0.4

(1) All balances were recorded in the “Other current assets” or “Other accrued liabilities” line items in the condensed consolidated statements of financial position.

XML

Inventories

3 Months Ended

Mar. 31, 2024

Inventory Disclosure [Abstract]

Inventories

Inventories

The “Inventories, net” line item in the condensed consolidated statements of financial position consisted of the following:

(Dollars in millions)	March 31, 2024		December 31, 2023
Raw materials	$	76.5	$	71.5
Work-in-process	41.6		45.6
Finished goods	32.8		36.4
Total inventories	$	150.9	$	153.5

XML

Balance Sheet Items

3 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Balance Sheet Items

Balance Sheet Items

Restricted Cash

Our restricted cash balance, which is subject to contractual restrictions and not readily available, is recorded in the “Cash and cash equivalents” line item in the condensed consolidated statements of financial position, and serves as collateral for letters of credit related to our environmental and workers’ compensation liabilities. Our restricted cash balance as of March 31, 2024 and December 31 2023 was as follows:

(Dollars in millions)	March 31, 2024		December 31, 2023
Restricted Cash	$	2.2	$	2.2

Accounts Receivable

The “Accounts receivable, net” line item in the condensed consolidated statements of financial position consisted of the following:

(Dollars in millions)	March 31, 2024		December 31, 2023
Accounts Receivable - Trade	$	146.6	$	143.2
Accounts Receivable - Other	12.6		18.7
Total	$	159.2	$	161.9

Accounts Payable

The “Accounts payable” line item in the condensed consolidated statements of financial position consisted of the following:

(Dollars in millions)	March 31, 2024		December 31, 2023
Accounts Payable - Trade	$	47.6	$	46.3
Accounts Payable - Other	4.1		4.0
Total	$	51.7	$	50.3

Supplemental Financial Information

Restructuring and Impairment Charges

The components of the “Restructuring and impairment charges” line item in the condensed consolidated statements of operations were as follows:

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Restructuring charges
Global workforce reduction	$	—	$	7.0
Facility consolidations	0.1		3.5
Total restructuring charges	$	0.1	$	10.5
Total restructuring and impairment charges	$	0.1	$	10.5

Restructuring Charges - Global Workforce Reduction

On February 16, 2023, we announced a plan to reduce our global workforce that was substantially completed in the first half of 2023, and concluded in the fourth quarter of 2023. The plan significantly reduced our manufacturing costs and operating expenses. We incurred $8.8 million in pre-tax restructuring charges related to this plan, all of which was in the form of cash-based expenditures and substantially all of which were related to employee severance and other termination benefits.

Restructuring Charges - Facility Consolidations

In late 2022 and early 2023, we announced our intention to exit certain facilities in the U.S. and Asia. The plan significantly reduced our manufacturing costs and operating expenses. We have incurred $8.2 million in pre-tax restructuring charges to-date related to these facility consolidations, most of which were in the form of accelerated depreciation.

As part of our facility consolidations plan, in February 2023, we entered into an asset purchase agreement to sell our high-performance engineered cellular elastomer business in our EMS operating segment for a purchase price of $1.8 million. The first phase of the deal, which pertained to the net assets other than the land and building, was completed in late March 2023, while the second phase, which pertained to the sale of the land and building, was completed in early September 2023. Of the $1.8 million purchase price, $1.0 million and $0.8 million were allocated to the first and second phases of the deal, respectively. The first phase of the deal included $3.7 million in assets and $3.1 million in liabilities. The assets were primarily comprised of accounts receivable, contract assets and inventories, while the liabilities were primarily comprised of accounts payable and other accrued liabilities, along with the previously recognized accrual against the net assets of the business based on the estimated fair value of the business in December 2022. We incurred $1.2 million of selling costs in 2023, which were recorded in “Selling, general and administrative expenses” in our condensed consolidated statements of operations.

As of March 31, 2024 we recognized $13.1 million of assets held for sale within the “Other current assets” financial statement line item of our condensed consolidated statements of financial position, representing the land and building at our Price Road facility in Chandler, Arizona. We still expect the sale of this facility to be completed in the second quarter of 2024. In September 2023, we entered into an agreement to sell one of our Suzhou, China facilities, which had a carrying value of $3.0 million, for $6.8 million resulting in a pre-tax gain of $1.9 million, inclusive of selling and disposal costs. The sale was completed in December 2023. The net impact of this transaction was recorded in the “Other operating (income) expense, net” line item in the condensed consolidated statements of operations.

Allocation of Restructuring and Impairment Charges to Operating Segments

The following table summarizes the allocation of restructuring and impairment charges to our operating segments:

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Advanced Electronics Solutions
Allocated restructuring charges	$	0.1	$	5.4
Elastomeric Material Solutions
Allocated restructuring charges	—		5.1
Total restructuring and impairment charges	$	0.1	$	10.5

Other Operating (Income) Expense, Net

The components of “Other operating (income) expense, net” line item in the condensed consolidated statements of operations, were as follows:

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
UTIS fire
Professional services	$	—	$	0.3
Insurance recoveries	—		(0.5)
Total UTIS fire	—		(0.2)
Total other operating (income) expense, net	$	—	$	(0.2)

In early February 2021, there was a fire at our UTIS manufacturing facility in Ansan, South Korea, which manufactures eSorba® polyurethane foams used in portable electronics and display applications. The site was safely evacuated and there were no reported injuries; however, there was extensive damage to the manufacturing site and some damage to nearby property. Commercial production at our new location in Siheung, South Korea commenced in late January 2023.

In connection with the UTIS fire, we recognized insurance recoveries of $0.5 million related to our ongoing insurance claims for business interruption and property damage for the three months ended March 31, 2023. We incurred $0.3 million for various professional services for the three months ended March 31, 2023, in connection with the pursuit of our insurance claims.

Interest Expense, Net

The components of “Interest expense, net” line item in the condensed consolidated statements of operations, were as follows:

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Interest on revolving credit facility	$	(0.5)	$	(3.4)
Line of credit fees	(0.3)		(0.3)
Debt issuance amortization costs	(0.1)		(0.3)
Interest income	0.1		0.5
Total interest expense, net	$	(0.8)	$	(3.5)

XML

Leases

3 Months Ended

Mar. 31, 2024

Leases [Abstract]

Leases

Leases

Finance Leases

Amortization expense related to our finance lease right-of-use assets, which is primarily included in the “Cost of sales” line item of the condensed consolidated statements of operations, was immaterial for each of the three-month periods ended March 31, 2024 and 2023. Interest expense related to our finance lease obligations, which is included in the “Interest expense, net” line item of the condensed consolidated statements of operations, was immaterial for each of the three-month periods ended March 31, 2024 and 2023.

Operating Leases

We have operating leases primarily related to manufacturing and R&D facilities as well as vehicles. Our expenses and payments for operating leases were as follows:

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Operating leases expense	$	1.3	$	1.0
Short-term leases expense	$	0.2	$	0.1
Payments on operating lease obligations	$	1.0	$	0.8

Lease Balances in Statements of Financial Position

The assets and liabilities balances related to finance and operating leases reflected in the condensed consolidated statements of financial position were as follows:

(Dollars in millions)	Financial Statement Line Item	March 31, 2024		December 31, 2023
Finance lease right-of-use assets	Property, plant and equipment, net	$	1.4	$	1.5
Operating lease right-of-use assets	Operating lease right-of-use assets	$	18.6	$	18.9
Finance lease obligations, current portion	Other accrued liabilities	$	0.4	$	0.4
Finance lease obligations, non-current portion	Other long-term liabilities	$	1.0	$	1.1
Total finance lease obligations		$	1.4	$	1.5
Operating lease obligations, current portion	Operating lease obligations, current portion	$	3.8	$	3.5
Operating lease obligations, non-current portion	Operating lease obligations, non-current portion	$	15.1	$	15.4
Total operating lease obligations		$	18.9	$	18.9

Net Future Minimum Lease Payments

The following table includes future minimum lease payments under finance and operating leases together with the present value of the net future minimum lease payments as of March 31, 2024:

	Finance						Operating
(Dollars in millions)	Leases Signed		Less: Leases Not Yet Commenced		Leases in Effect		Leases Signed		Less: Leases Not Yet Commenced		Leases in Effect
2024	$	0.3	$	—	$	0.3	$	3.9	$	(0.1)	$	3.8
2025	1.5		(1.1)		0.4		5.2		(1.1)		4.1
2026	1.6		(1.2)		0.4		4.5		(1.2)		3.3
2027	1.4		(1.2)		0.2		3.7		(1.1)		2.6
2028	1.3		(1.2)		0.1		2.6		(0.8)		1.8
Thereafter	5.1		(5.0)		0.1		11.9		(4.8)		7.1
Total lease payments	11.2		(9.7)		1.5		31.8		(9.1)		22.7
Less: Interest	(1.8)		1.7		(0.1)		(6.1)		2.3		(3.8)
Present Value of Net Future Minimum Lease Payments	$	9.4	$	(8.0)	$	1.4	$	25.7	$	(6.8)	$	18.9

The following table includes information regarding the lease term and discount rates utilized in the calculation of the present value of net future minimum lease payments:

	March 31, 2024	December 31, 2023
Weighted Average Remaining Lease Term
Finance leases	3.9 years	4.0 years
Operating leases	6.7 years	7.0 years
Weighted Average Discount Rate
Finance leases	4.22%	4.14%
Operating leases	5.37%	5.35%

Leases

Leases

Finance Leases

Amortization expense related to our finance lease right-of-use assets, which is primarily included in the “Cost of sales” line item of the condensed consolidated statements of operations, was immaterial for each of the three-month periods ended March 31, 2024 and 2023. Interest expense related to our finance lease obligations, which is included in the “Interest expense, net” line item of the condensed consolidated statements of operations, was immaterial for each of the three-month periods ended March 31, 2024 and 2023.

Operating Leases

We have operating leases primarily related to manufacturing and R&D facilities as well as vehicles. Our expenses and payments for operating leases were as follows:

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Operating leases expense	$	1.3	$	1.0
Short-term leases expense	$	0.2	$	0.1
Payments on operating lease obligations	$	1.0	$	0.8

Lease Balances in Statements of Financial Position

The assets and liabilities balances related to finance and operating leases reflected in the condensed consolidated statements of financial position were as follows:

(Dollars in millions)	Financial Statement Line Item	March 31, 2024		December 31, 2023
Finance lease right-of-use assets	Property, plant and equipment, net	$	1.4	$	1.5
Operating lease right-of-use assets	Operating lease right-of-use assets	$	18.6	$	18.9
Finance lease obligations, current portion	Other accrued liabilities	$	0.4	$	0.4
Finance lease obligations, non-current portion	Other long-term liabilities	$	1.0	$	1.1
Total finance lease obligations		$	1.4	$	1.5
Operating lease obligations, current portion	Operating lease obligations, current portion	$	3.8	$	3.5
Operating lease obligations, non-current portion	Operating lease obligations, non-current portion	$	15.1	$	15.4
Total operating lease obligations		$	18.9	$	18.9

Net Future Minimum Lease Payments

The following table includes future minimum lease payments under finance and operating leases together with the present value of the net future minimum lease payments as of March 31, 2024:

	Finance						Operating
(Dollars in millions)	Leases Signed		Less: Leases Not Yet Commenced		Leases in Effect		Leases Signed		Less: Leases Not Yet Commenced		Leases in Effect
2024	$	0.3	$	—	$	0.3	$	3.9	$	(0.1)	$	3.8
2025	1.5		(1.1)		0.4		5.2		(1.1)		4.1
2026	1.6		(1.2)		0.4		4.5		(1.2)		3.3
2027	1.4		(1.2)		0.2		3.7		(1.1)		2.6
2028	1.3		(1.2)		0.1		2.6		(0.8)		1.8
Thereafter	5.1		(5.0)		0.1		11.9		(4.8)		7.1
Total lease payments	11.2		(9.7)		1.5		31.8		(9.1)		22.7
Less: Interest	(1.8)		1.7		(0.1)		(6.1)		2.3		(3.8)
Present Value of Net Future Minimum Lease Payments	$	9.4	$	(8.0)	$	1.4	$	25.7	$	(6.8)	$	18.9

The following table includes information regarding the lease term and discount rates utilized in the calculation of the present value of net future minimum lease payments:

	March 31, 2024	December 31, 2023
Weighted Average Remaining Lease Term
Finance leases	3.9 years	4.0 years
Operating leases	6.7 years	7.0 years
Weighted Average Discount Rate
Finance leases	4.22%	4.14%
Operating leases	5.37%	5.35%

XML

Goodwill and Other Intangible Assets

3 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets

Goodwill and Other Intangible Assets

Goodwill

The changes in the net carrying amount of goodwill by operating segment were as follows:

(Dollars in millions)	Advanced Electronics Solutions		Elastomeric Material Solutions		Other		Total
December 31, 2023	$	117.7	$	239.9	$	2.2	$	359.8
Foreign currency translation adjustment	(1.5)		(1.1)		—		$	(2.6)
March 31, 2024	$	116.2	$	238.8	$	2.2	$	357.2

Other Intangible Assets

The carrying amount of other intangible assets were as follows:

	March 31, 2024						December 31, 2023
(Dollars in millions)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Customer relationships	$	177.0	$	91.4	$	85.6	$	177.9	$	90.0	$	87.9
Technology	76.8		58.6		18.2		77.4		58.1		19.3
Trademarks and trade names	19.3		7.4		11.9		19.4		7.4		12.0
Covenants not to compete	1.3		1.0		0.3		1.3		0.9		0.4
Total definite-lived other intangible assets	274.4		158.4		116.0		276.0		156.4		119.6
Indefinite-lived other intangible asset	4.3		—		4.3		4.3		—		4.3
Total other intangible assets	$	278.7	$	158.4	$	120.3	$	280.3	$	156.4	$	123.9

In the table above, gross carrying amounts and accumulated amortization may differ from prior periods due to foreign exchange rate fluctuations.

Amortization expense was $3.1 million and $3.3 million for the three months ended March 31, 2024 and 2023, respectively. The estimated future amortization expense is $9.3 million, $10.8 million, $10.4 million, $10.0 million, and $7.8 million in 2024, 2025, 2026, 2027 and 2028, respectively. These amounts could vary based on changes in foreign currency exchange rates.

The weighted average amortization period as of March 31, 2024, by definite-lived other intangible asset class, is presented in the table below:

	Weighted Average Remaining Amortization Period
Customer relationships	7.3 years
Technology	3.2 years
Trademarks and trade names	9.8 years
Covenants not to compete	0.4 years
Total definite-lived other intangible assets	6.9 years

XML

Pension Benefits and Other Postretirement Benefits

3 Months Ended

Mar. 31, 2024

Retirement Benefits [Abstract]

Pension Benefits and Other Postretirement Benefits

Pension Benefits and Other Postretirement Benefits

Pension and Other Postretirement Benefit Plans

As of March 31, 2024, we had one qualified noncontributory defined benefit pension plan, the Union Plan, which was frozen and ceased accruing benefits in 2013. Additionally, we sponsor other postretirement benefit plans, including multiple fully insured or self-funded medical plans and life insurance plans for certain retirees. The measurement date for all plans is December 31st for each respective plan year.

Components of Net Periodic Benefit Cost (Credit)

The components of net periodic benefit (credit) cost were as follows:

	Pension Benefits
	Three Months Ended
	March 31,
(Dollars in millions)	2024		2023
Interest cost	0.2		0.3
Expected return of plan assets	(0.3)		(0.4)
Amortization of net loss (gain)	0.1		0.1
Net periodic benefit cost (credit)	$	—	$	—

Employer Contributions

There were no required or voluntary contributions made to the Union Plan for each of the three months ended March 31, 2024 and 2023. Additionally, we are not required to make additional contributions to the Union Plan for the remainder of 2024.

As there is no funding requirement for the other postretirement benefit plans, we funded these benefit payments as incurred, which were immaterial for each of the three months ended March 31, 2024 and 2023, using cash from operations.

XML

Debt

3 Months Ended

Mar. 31, 2024

Debt Disclosure [Abstract]

Debt

Debt

On March 24, 2023, we entered into a Fifth Amended Credit Agreement with each of the lenders party thereto, JPMorgan Chase Bank, N.A. as administrative agent, and HSBC Bank USA, National Association, Wells Fargo Bank, National Association, Citibank, N.A. and Citizens Bank, N.A. as Co-Syndication Agents. The Fifth Amended Credit Agreement amends and restates the Fourth Amended Credit Agreement, and provides for (1) a revolving credit facility with up to $450.0 million of revolving loans, with sub-limits for multicurrency borrowings, letters of credit and swing-line notes, and (2) a $225.0 million expansion feature. Borrowings may be used to finance working capital needs, for letters of credit and for general corporate purposes in the ordinary course of business, including the financing of permitted acquisitions (as defined in the Fifth Amended Credit Agreement). The Fifth Amended Credit Agreement extends the maturity, the date on which all amounts borrowed or outstanding under the Fifth Amended Credit Agreement are due, from March 31, 2024 to March 24, 2028.

All obligations under the Fifth Amended Credit Agreement are guaranteed by each of our existing and future material domestic subsidiaries, as defined in the Fifth Amended Credit Agreement (the Guarantors). The obligations are also secured by a Fifth Amended and Restated Pledge and Security Agreement, dated as of March 24, 2023, entered into by us and the Guarantors which grants to the administrative agent, for the benefit of the lenders, a security interest, subject to certain exceptions, in substantially all of the non-real estate assets of ours and the Guarantors. These assets include, but are not limited to, receivables, equipment, intellectual property, inventory, and stock in certain subsidiaries.

Borrowings under the Fifth Amended Credit Agreement bear interest based on one of two options. Alternate base rate loans will bear interest at a rate that includes a base reference rate plus a spread of 62.5 to 100.0 basis points, depending on our leverage ratio. The base reference rate will be the greater of the (1) prime rate, (2) federal funds effective rate plus 50 basis points, and (3) one-month Term SOFR plus 110 basis points. Loans bearing an interest rate determined by reference to the Adjusted Term SOFR Rate, the Adjusted EURIBOR, or the Adjusted TIBOR (each as defined in the Fifth Amended Credit Agreement) will bear interest based on the screen rate plus a spread of 162.5 to 200.0 basis points, depending on our leverage ratio. Based on our leverage ratio as of March 31, 2024, the spread was 162.5 basis points.

In addition to interest payable on the principal amount of indebtedness outstanding, we incur an annual fee of 25 to 35 basis points (based upon our leverage ratio), paid quarterly, of the unused amount of the lenders’ commitments under the Fifth Amended Credit Agreement.

The Fifth Amended Credit Agreement contains customary representations and warranties, covenants, mandatory prepayments and events of default under which the Company’s payment obligations may be accelerated. The financial covenants include a

requirement to maintain (1) a total net leverage ratio of no more than 3.25 to 1.00, subject to a one-time election to increase the maximum total net leverage ratio to 3.75 to 1.00 for one fiscal year in connection with a permitted acquisition, and (2) an interest coverage ratio of no less than 3.00 to 1.00. We are permitted to net up to $50.0 million of unrestricted domestic cash and cash equivalents in the calculation of the total net leverage ratio. The Fifth Amended Credit Agreement generally permits us to pay cash dividends to our shareholders, provided that (i) no default or event of default has occurred and is continuing or would result from the dividend payment and (ii) our total net leverage ratio does not exceed 2.75 to 1.00. If our total net leverage ratio exceeds 2.75 to 1.00, we may nonetheless make up to $20.0 million in restricted payments, including cash dividends, during the fiscal year, provided that no default or event of default has occurred and is continuing or would result from the payments. Our total net leverage ratio did not exceed 2.75 to 1.00 and our interest coverage ratio was greater than or equal to 3.00 to 1.00 as of March 31, 2024.

There were no borrowings under the Fifth Amended Credit Agreement during the three months ended March 31, 2024 or the three months ended March 31, 2023. We are not required to make any quarterly principal payments under the Fifth Amended Credit Agreement. We made a $30.0 million discretionary principal payment during the three months ended March 31, 2024, and we made a $25.0 million discretionary principal payment during the three months ended March 31, 2023.

We had no outstanding borrowings under our revolving credit facility as of March 31, 2024, and $30.0 million as of December 31, 2023. We had $2.0 million and $2.1 million of outstanding line of credit issuance costs as of March 31, 2024 and December 31, 2023, respectively, which will be amortized over the life of the Fifth Amended Credit Agreement.

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

We are currently engaged in the following material environmental and legal proceedings:

Asbestos

Overview

We, like many other industrial companies, have been named as a defendant in a number of lawsuits filed in courts across the country by persons alleging personal injury from exposure to products containing asbestos. We have never mined, milled, manufactured or marketed asbestos; rather, we made and provided to industrial users a limited number of products that contained encapsulated asbestos, but we stopped manufacturing these products in the late 1980s. Most of the claims filed against us involve numerous defendants, sometimes as many as several hundred. In virtually all of the cases against us, the plaintiffs are seeking unspecified damages above a jurisdictional minimum against multiple defendants who may have manufactured, sold or used asbestos-containing products to which the plaintiffs were allegedly exposed and from which they purportedly suffered injury. Most of these cases are being litigated in Maryland, Illinois, Missouri and New York; however, we are also defending cases in other states. We continue to vigorously defend these cases, primarily on the basis of the plaintiffs’ inability to establish compensable loss as a result of exposure to our products. The indemnity and defense costs of our asbestos-related product liability litigation to date have been substantially covered by insurance.

The following table summarizes the change in number of asbestos claims outstanding for the three months ended March 31, 2024:

	Asbestos Claims
Claims outstanding as of January 1, 2024	506
New claims filed	35
Pending claims concluded(1)	(36)
Claims outstanding as of March 31, 2024	505

(1) For the three months ended March 31, 2024, 32 claims were dismissed and 4 claims were settled. Settlements totaled approximately $1.5 million for the three months ended March 31, 2024.

Impact on Financial Statements

We recognize a liability for asbestos-related contingencies that are probable of occurrence and reasonably estimable. In connection with the recognition of liabilities for asbestos-related matters, we record asbestos-related insurance receivables that are deemed probable.

The liability projection period covers all current and future indemnity and defense costs through 2064, which represents the expected end of our asbestos liability exposure with no further ongoing claims expected beyond that date. This conclusion was based on our history and experience with the claims data, the diminished volatility and consistency of observable claims data, the period of time that has elapsed since we stopped manufacturing products that contained encapsulated asbestos and an expected downward trend in claims due to the average age of our claimants, which is approaching the average life expectancy.

To date, the indemnity and defense costs of our asbestos-related product liability litigation have been substantially covered by insurance. Although we have exhausted coverage under some of our insurance policies, we believe that we have applicable primary, excess and/or umbrella coverage for claims arising with respect to most of the years during which we manufactured and marketed asbestos-containing products. In addition, we have entered into a cost sharing agreement with most of our primary, excess and umbrella insurance carriers to facilitate the ongoing administration and payment of claims covered by the carriers. The cost sharing agreement may be terminated by any party, but will continue until a party elects to terminate it. As of the filing date for this report, the agreement has not been terminated, and no carrier had informed us that it intends to terminate the agreement. We expect to continue to exhaust individual primary, excess and umbrella coverages over time, and there is no assurance that such exhaustion will not accelerate due to additional claims, damages and settlements or that coverage will be available as expected. We are responsible for uninsured indemnity and defense costs, and we incurred an immaterial amount of expenses for each of the three month periods ended March 31, 2024 and 2023, respectively, related to such costs.

The amounts recorded for the asbestos-related liability and the related insurance receivables are based on facts known at the time and a number of assumptions. However, projecting for future events, such as the number of new claims to be filed each year, the average cost of disposing of such claims, the length of time it takes to dispose of such claims, coverage issues among insurers and the continuing solvency of various insurance companies, as well as the numerous uncertainties surrounding asbestos litigation in the United States, could cause the actual liability and insurance recoveries for us to be higher or lower than those projected or recorded. The full extent of our financial exposure to asbestos-related litigation remains very difficult to estimate and could include both compensatory and punitive damage awards.

Changes recorded in the estimated liability and estimated insurance recovery based on projections of asbestos litigation and corresponding insurance coverage, result in the recognition of expense or income.

Our projected asbestos-related liabilities and insurance receivables were as follows:

(Dollars in millions)	March 31, 2024		December 31, 2023
Asbestos-related liabilities	$	61.5	$	61.5
Asbestos-related insurance receivables	$	56.5	$	56.5

Environmental Voluntary Corrective Action Program

Our location in Rogers, Connecticut is part of the Connecticut Voluntary Corrective Action Program (VCAP). As part of this program, we partnered with the Connecticut Department of Energy and Environmental Protection (CT DEEP) to determine the corrective actions to be taken at the site related to contamination issues. We evaluated this matter and completed internal due diligence work related to the site in the fourth quarter of 2015. Remediation activities on the site are ongoing and are recorded as reductions to the accrual as they are incurred. We have incurred $2.0 million of aggregate remediation costs through March 31, 2024, and the accrual for future remediation efforts is $0.7 million.

Other Matters

In addition to the above issues, the nature and scope of our business brings us in regular contact with the general public and a variety of businesses and government agencies. Such activities inherently subject us to the possibility of litigation, including environmental and product liability matters that are defended and handled in the ordinary course of business. We have established accruals for matters for which management considers a loss to be probable and reasonably estimable. It is the opinion of management that facts known at the present time do not indicate that such litigation will have a material adverse impact on our results of operations, financial position or cash flows.

XML

Earnings Per Share

3 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

Basic earnings per share is based on the weighted average number of common shares outstanding. Diluted earnings per share is based on the weighted average number of common shares outstanding and all dilutive potential common shares outstanding.

The following table sets forth the computation of basic and diluted earnings per share:

(Dollars and shares in millions, except per share amounts)	Three Months Ended
	March 31, 2024		March 31, 2023
Numerator:
Net income (loss)	$	7.8	$	(3.5)
Denominator:
Weighted-average shares outstanding - basic	18.6		18.6
Effect of dilutive shares	0.1		—
Weighted-average shares outstanding - diluted	18.7		18.6
Basic earnings (loss) per share	$	0.42	$	(0.19)
Diluted earnings (loss) per share	$	0.42	$	(0.19)

Dilutive shares are calculated using the treasury stock method and primarily include unvested restricted stock units. Anti-dilutive shares are excluded from the calculation of diluted shares and diluted earnings per share. For the three months ended March 31, 2024 and 2023,

XML

Capital Stock and Equity Compensation

3 Months Ended

Mar. 31, 2024

Share-Based Payment Arrangement, Noncash Expense [Abstract]

Capital Stock and Equity Compensation

Capital Stock and Equity Compensation

Share Repurchases

In 2015, we initiated a share repurchase program (the “Program”) of up to $100.0 million of the Company’s capital stock to mitigate the dilutive effects of stock option exercises and vesting of restricted stock units granted by the Company, in addition to enhancing shareholder value. The Program has no expiration date and may be suspended or discontinued at any time without notice. For the three months ended March 31, 2024, we purchased 1,500 shares for a total value of $0.2 million using cash from operations and cash on hand. As of March 31, 2024, $23.8 million remained available to purchase under the Program. Our stock repurchases may occur from time to time through open market purchases, privately negotiated transactions or plans designed to comply with Rule 10b5-1 promulgated under the Exchange Act.

(Dollars in millions, except shares and per share amounts)
Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet be Purchased under the Plans or Programs
March 1, 2024 to March 31, 2024	1,500	$	109.92	1,500	$	23.8

Equity Compensation

Performance-Based Restricted Stock Units

As of March 31, 2024, we had outstanding performance-based restricted stock units with a market condition from 2024 and 2023. These awards generally cliff vest at the end of a three-year measurement period. However, employees whose employment terminates during the measurement period due to death, disability, or, in certain cases, retirement may receive a pro-rata payout based on the number of days they were employed during the measurement period. Participants are eligible to be awarded shares ranging from 0% to 200% of the original award amount, based on certain defined performance measures.

The performance-based restricted stock units with a market condition have one measurement criterion: the three-year total shareholder return (“TSR”) on our capital stock as compared to that of a specified group of peer companies. The fair value of this measurement criterion was determined on the grant date using a Monte Carlo simulation valuation model. We recognize compensation expense on all of these awards on a straight-line basis over the vesting period with no changes for final projected payout of the awards. We account for forfeitures as they occur.

The following table sets forth the assumptions used in the Monte Carlo calculation for each material award granted in 2024 and 2023:

	February 19, 2024	February 13, 2024	February 9, 2023
Expected volatility	46.3%	46.2%	53.2%
Expected term (in years)	2.9	2.9	2.9
Risk-free interest rate	4.35%	4.35%	4.08%

Expected volatility – In determining expected volatility, we have considered a number of factors, including historical volatility.

Expected term – We use the vesting period of the award to determine the expected term assumption for the Monte Carlo simulation valuation model.

Risk-free interest rate – We use an implied “spot rate” yield on U.S. Treasury Constant Maturity rates as of the grant date for our assumption of the risk-free interest rate.

Expected dividend yield – We do not currently pay dividends on our capital stock; therefore, a dividend yield of 0% was used in the Monte Carlo simulation valuation model.

As of March 31, 2024, we had outstanding performance-based restricted stock units with a performance condition from 2024. These awards generally cliff vest at the end of a two-year performance period. However, employees whose employment terminates during the measurement period due to death, disability, or, in certain cases, retirement may receive a pro-rata payout based on the number of days they were employed during the measurement period. Participants are eligible to be awarded shares ranging from 0% to 200% of the original award amount, based on certain defined performance measures.

The performance-based restricted stock units with a performance condition have one measurement criterion: 2025 net revenue. The fair value of these awards was determined based on the market value of the underlying stock price at the grant date with cumulative compensation expense recognized to-date being increased or decreased based on the changes in the forecasted payout percentage as of the end of each reporting period. We account for forfeitures as they occur.

A summary of activity of the outstanding performance-based restricted stock units for the three months ended March 31, 2024 is presented below:

	Performance-Based Restricted Stock Units
Awards outstanding as of December 31, 2023	73,528
Awards granted	79,700
Stock issued	—
Awards cancelled	(26,737)
Awards outstanding as of March 31, 2024	126,491

We recognized $1.3 million and $0.1 million of compensation expense for performance-based restricted stock units for the three months ended March 31, 2024 and 2023, respectively.

Time-Based Restricted Stock Units

As of March 31, 2024, we had time-based restricted stock unit awards from 2024, 2023, 2022 and 2021 outstanding. The outstanding awards all ratably vest on the first, second and third anniversaries of the original grant date. However, employees whose employment terminates during the measurement period due to death, disability, or, in certain cases, retirement may receive a pro-rata payout based on the number of days they were employed subsequent to the last grant anniversary date. Each time-based restricted stock unit represents a right to receive one share of Rogers’ capital stock at the end of the vesting period. The fair value of the award is determined by the market value of the underlying stock price at the grant date. We recognize compensation expense on all of these awards on a straight-line basis over the vesting period. We account for forfeitures as they occur.

A summary of activity of the outstanding time-based restricted stock units for the three months ended March 31, 2024 is presented below:

	Time-Based Restricted Stock Units
Awards outstanding as of December 31, 2023	100,999
Awards granted	67,480
Stock issued	(34,261)
Awards cancelled	(3,688)
Awards outstanding as of March 31, 2024	130,530

We recognized $1.9 million and $2.1 million of compensation expense for time-based restricted stock units for the three months ended March 31, 2024 and 2023, respectively.

Deferred Stock Units

We grant deferred stock units to non-management directors. These awards are fully vested on the date of grant and the related shares are generally issued on the 13-month anniversary of the grant date unless the individual elects to defer the receipt of those shares. Each deferred stock unit results in the issuance of one share of Rogers’ capital stock. The grant of deferred stock units is typically done annually during the second quarter of each year. The fair value of the award is determined by the market value of the underlying stock price at the grant date.

A summary of activity of the outstanding deferred stock units for the three months ended March 31, 2024 is presented below:

	Deferred Stock Units
Awards outstanding as of December 31, 2023	8,100
Awards granted	450
Stock issued	(950)
Awards outstanding as of March 31, 2024	7,600

We recognized an immaterial amount of compensation expense and no compensation expense for deferred stock units for the three months ended March 31, 2024 and 2023, respectively.

Employee Stock Purchase Plan

We have an ESPP that allows eligible employees to purchase, through payroll deductions, shares of our capital stock at a discount to fair market value. The ESPP has two six-month offering periods each year, the first beginning in mid-December and ending in mid-June and the second beginning in mid-June and ending in mid-December. The ESPP contains a look-back feature that allows the employee to acquire shares of our capital stock at a 15% discount from the underlying market price at the beginning or end of the applicable period, whichever is lower. We recognize compensation expense on this plan ratably over the offering period based on the fair value of the anticipated number of shares that will be issued at the end of each offering period. Compensation expense is adjusted at the end of each offering period for the actual number of shares issued. Fair value is determined based on two factors: (i) the 15% discount on the underlying stock’s market value on the first day of the applicable offering period, and (ii) the fair value of the look-back feature determined by using the Black-Scholes model. We recognized $0.2 million of compensation expense associated with the ESPP for the three months ended March 31, 2024.

XML

Operating Segment Information

3 Months Ended

Mar. 31, 2024

Segment Reporting [Abstract]

Operating Segment Information

Operating Segment Information

Our reporting structure is comprised of the following strategic operating segments: AES and EMS. The remaining operations, which represent our non-core businesses, are reported in the Other operating segment.

Our AES operating segment designs, develops, manufactures and sells circuit materials, ceramic substrate materials, busbars and cooling solutions for applications in EV/HEV, automotive (e.g., ADAS), aerospace and defense (e.g., antenna systems, communication systems and phased array radar systems), renewable energy (e.g., wind and solar), wireless infrastructure (e.g., power amplifiers, antennas and small cells), mass transit, industrial (e.g., variable frequency drives), connected devices (e.g., mobile internet devices and thermal solutions) and wired infrastructure (e.g., computing and internet protocol infrastructure) markets.

Our EMS operating segment designs, develops, manufactures and sells engineered material solutions for a wide variety of applications and markets. These include polyurethane and silicone materials used in cushioning, gasketing and sealing, and vibration management applications for EV/HEV, general industrial, portable electronics, automotive, mass transit, aerospace and defense, footwear and impact mitigation markets; customized silicones used in flex heater and semiconductor thermal applications for EV/HEV, general industrial, portable electronics, automotive, mass transit, aerospace and defense and medical

markets; and polytetrafluoroethylene and ultra-high molecular weight polyethylene materials used in wire and cable protection, electrical insulation, conduction and shielding, hose and belt protection, vibration management, cushioning, gasketing and sealing, and venting applications for EV/HEV, general industrial, automotive and aerospace and defense markets.

Our Other operating segment consists of elastomer components for applications in the general industrial market, as well as elastomer floats for level sensing in fuel tanks, motors, and storage tanks applications in the general industrial and automotive markets.

The following table presents a disaggregation of revenue from contracts with customers and other pertinent financial information, for the periods indicated; inter-segment sales have been eliminated from the net sales data:

(Dollars in millions)	Advanced Electronics Solutions		Elastomeric Material Solutions		Other		Total
Three Months Ended March 31, 2024
Net sales - recognized over time	$	46.4	$	1.8	$	5.4	$	53.6
Net sales - recognized at a point in time	75.7		83.9		0.2		159.8
Total net sales	$	122.1	$	85.7	$	5.6	$	213.4
Operating income	$	4.4	$	5.3	$	2.0	$	11.7
Three Months Ended March 31, 2023
Net sales - recognized over time	$	62.4	$	9.0	$	3.9	$	75.3
Net sales - recognized at a point in time	73.5		93.2		1.8		168.5
Total net sales	$	135.9	$	102.2	$	5.7	$	243.8
Operating income	$	(5.5)	$	3.2	$	2.0	$	(0.3)

Net sales by operating segment and by geographic area were as follows:

(Dollars in millions)	Net Sales(1)
Region/Country	Advanced Electronics Solutions		Elastomeric Material Solutions		Other		Total
Three Months Ended March 31, 2024
United States	$	20.4	$	33.1	$	1.0	$	54.5
Other Americas	0.6		3.9		0.1		4.6
Total Americas	21.0		37.0		1.1		59.1
China	34.3		20.4		1.6		56.3
Other APAC	23.7		6.6		1.1		31.4
Total APAC	58.0		27.0		2.7		87.7
Germany	21.9		7.9		0.2		30.0
Other EMEA	21.2		13.8		1.6		36.6
Total EMEA	43.1		21.7		1.8		66.6
Total net sales	$	122.1	$	85.7	$	5.6	$	213.4
Three Months Ended March 31, 2023
United States	$	21.5	$	41.9	$	1.1	$	64.5
Other Americas	2.4		9.2		0.1		11.7
Total Americas	23.9		51.1		1.2		76.2
China	38.4		20.2		2.4		61.0
Other APAC	24.9		7.0		0.5		32.4
Total APAC	63.3		27.2		2.9		93.4
Germany	24.0		8.0		0.1		32.1
Other EMEA	24.7		15.9		1.5		42.1
Total EMEA	48.7		23.9		1.6		74.2
Total net sales	$	135.9	$	102.2	$	5.7	$	243.8

(1)Net sales are allocated to countries based on the location of the customer. The table above lists individual countries with 10% or more of net sales for the periods indicated.

We have contract assets primarily related to unbilled revenue for revenue recognized related to products that are deemed to have no alternative use whereby we have the right to payment. Revenue is recognized in advance of billing to the customer in these circumstances as billing is typically performed at the time of shipment to the customer. The unbilled revenue is included in contract assets on the condensed consolidated statements of financial position.

Contract assets by operating segment were as follows:

(Dollars in millions)	March 31, 2024		December 31, 2023
Advanced Electronics Solutions	$	35.6	$	41.4
Elastomeric Material Solutions	0.7		0.4
Other	4.0		3.4
Total contract assets	$	40.3	$	45.2

We did not have any contract liabilities as of March 31, 2024 or December 31, 2023. No impairment losses were recognized for each of the three month periods ended March 31, 2024 and 2023, respectively, on any receivables or contract assets arising from our contracts with customers.

XML

Supplemental Financial Information

3 Months Ended

Mar. 31, 2024

Supplemental Income Statement Elements [Abstract]

Supplemental Financial Information

Balance Sheet Items

Restricted Cash

Our restricted cash balance, which is subject to contractual restrictions and not readily available, is recorded in the “Cash and cash equivalents” line item in the condensed consolidated statements of financial position, and serves as collateral for letters of credit related to our environmental and workers’ compensation liabilities. Our restricted cash balance as of March 31, 2024 and December 31 2023 was as follows:

(Dollars in millions)	March 31, 2024		December 31, 2023
Restricted Cash	$	2.2	$	2.2

Accounts Receivable

The “Accounts receivable, net” line item in the condensed consolidated statements of financial position consisted of the following:

(Dollars in millions)	March 31, 2024		December 31, 2023
Accounts Receivable - Trade	$	146.6	$	143.2
Accounts Receivable - Other	12.6		18.7
Total	$	159.2	$	161.9

Accounts Payable

The “Accounts payable” line item in the condensed consolidated statements of financial position consisted of the following:

(Dollars in millions)	March 31, 2024		December 31, 2023
Accounts Payable - Trade	$	47.6	$	46.3
Accounts Payable - Other	4.1		4.0
Total	$	51.7	$	50.3

Supplemental Financial Information

Restructuring and Impairment Charges

The components of the “Restructuring and impairment charges” line item in the condensed consolidated statements of operations were as follows:

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Restructuring charges
Global workforce reduction	$	—	$	7.0
Facility consolidations	0.1		3.5
Total restructuring charges	$	0.1	$	10.5
Total restructuring and impairment charges	$	0.1	$	10.5

Restructuring Charges - Global Workforce Reduction

On February 16, 2023, we announced a plan to reduce our global workforce that was substantially completed in the first half of 2023, and concluded in the fourth quarter of 2023. The plan significantly reduced our manufacturing costs and operating expenses. We incurred $8.8 million in pre-tax restructuring charges related to this plan, all of which was in the form of cash-based expenditures and substantially all of which were related to employee severance and other termination benefits.

Restructuring Charges - Facility Consolidations

In late 2022 and early 2023, we announced our intention to exit certain facilities in the U.S. and Asia. The plan significantly reduced our manufacturing costs and operating expenses. We have incurred $8.2 million in pre-tax restructuring charges to-date related to these facility consolidations, most of which were in the form of accelerated depreciation.

As part of our facility consolidations plan, in February 2023, we entered into an asset purchase agreement to sell our high-performance engineered cellular elastomer business in our EMS operating segment for a purchase price of $1.8 million. The first phase of the deal, which pertained to the net assets other than the land and building, was completed in late March 2023, while the second phase, which pertained to the sale of the land and building, was completed in early September 2023. Of the $1.8 million purchase price, $1.0 million and $0.8 million were allocated to the first and second phases of the deal, respectively. The first phase of the deal included $3.7 million in assets and $3.1 million in liabilities. The assets were primarily comprised of accounts receivable, contract assets and inventories, while the liabilities were primarily comprised of accounts payable and other accrued liabilities, along with the previously recognized accrual against the net assets of the business based on the estimated fair value of the business in December 2022. We incurred $1.2 million of selling costs in 2023, which were recorded in “Selling, general and administrative expenses” in our condensed consolidated statements of operations.

As of March 31, 2024 we recognized $13.1 million of assets held for sale within the “Other current assets” financial statement line item of our condensed consolidated statements of financial position, representing the land and building at our Price Road facility in Chandler, Arizona. We still expect the sale of this facility to be completed in the second quarter of 2024. In September 2023, we entered into an agreement to sell one of our Suzhou, China facilities, which had a carrying value of $3.0 million, for $6.8 million resulting in a pre-tax gain of $1.9 million, inclusive of selling and disposal costs. The sale was completed in December 2023. The net impact of this transaction was recorded in the “Other operating (income) expense, net” line item in the condensed consolidated statements of operations.

Allocation of Restructuring and Impairment Charges to Operating Segments

The following table summarizes the allocation of restructuring and impairment charges to our operating segments:

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Advanced Electronics Solutions
Allocated restructuring charges	$	0.1	$	5.4
Elastomeric Material Solutions
Allocated restructuring charges	—		5.1
Total restructuring and impairment charges	$	0.1	$	10.5

Other Operating (Income) Expense, Net

The components of “Other operating (income) expense, net” line item in the condensed consolidated statements of operations, were as follows:

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
UTIS fire
Professional services	$	—	$	0.3
Insurance recoveries	—		(0.5)
Total UTIS fire	—		(0.2)
Total other operating (income) expense, net	$	—	$	(0.2)

In early February 2021, there was a fire at our UTIS manufacturing facility in Ansan, South Korea, which manufactures eSorba® polyurethane foams used in portable electronics and display applications. The site was safely evacuated and there were no reported injuries; however, there was extensive damage to the manufacturing site and some damage to nearby property. Commercial production at our new location in Siheung, South Korea commenced in late January 2023.

In connection with the UTIS fire, we recognized insurance recoveries of $0.5 million related to our ongoing insurance claims for business interruption and property damage for the three months ended March 31, 2023. We incurred $0.3 million for various professional services for the three months ended March 31, 2023, in connection with the pursuit of our insurance claims.

Interest Expense, Net

The components of “Interest expense, net” line item in the condensed consolidated statements of operations, were as follows:

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Interest on revolving credit facility	$	(0.5)	$	(3.4)
Line of credit fees	(0.3)		(0.3)
Debt issuance amortization costs	(0.1)		(0.3)
Interest income	0.1		0.5
Total interest expense, net	$	(0.8)	$	(3.5)

XML

Income Taxes

3 Months Ended

Mar. 31, 2024

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

The below discussion of the effective tax rate for the periods presented in the consolidated statements of operations is in comparison to the 21% U.S. statutory federal income tax rate.

Our effective tax rate was 32.8% in the first quarter of 2024. During the first quarter of 2024, our effective tax rate was unfavorably impacted primarily by the write-off of deferred tax assets related to stock compensation.

During the first quarter of 2023, our effective tax rate was 3.5%. During the first quarter of 2023, our effective tax rate was unfavorably impacted primarily by an increase in the valuation allowance attributable to loss jurisdictions in which no benefit is anticipated to be realized.

The OECD Pillar 2 guidelines published to date include transition and safe harbor rules around the implementation of the Pillar 2 global minimum tax of 15%. Based on current enacted legislation effective in 2024 and our structure, we do not expect a material impact in 2024. We are monitoring developments and evaluating the impacts these new rules will have on our future effective income tax rate, tax payments, financial condition, and results of operations.

XML

Recent Accounting Standards

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Recent Accounting Standards

Recent Accounting Standards

Recently Issued Standards

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU 2023-07 enhances segment reporting under Topic 280 by expanding the breadth and frequency of segment disclosures. This amendment will improve the disclosures about a public entity’s reportable segments and address requests from investors for additional, more detailed information about a reportable segment’s expenses. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. Adoption of the standard requires using the retrospective approach. We are currently evaluating the potential impact of adopting this guidance on our consolidated financial statements and accompanying notes.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments in this update address investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This update also includes certain other amendments to improve the effectiveness of income tax disclosures. The ASU is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. Adoption of the standard should be applied on a prospective basis and retrospective application to all periods presented is permitted. We are currently evaluating the potential impact of adopting this guidance on our consolidated financial statements and accompanying notes.

XML

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net income (loss)	$ 7.8	$ (3.5)

XML

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML

Recent Accounting Standards (Policies)

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Recently Issued Standards

Recently Issued Standards

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. ASU 2023-07 enhances segment reporting under Topic 280 by expanding the breadth and frequency of segment disclosures. This amendment will improve the disclosures about a public entity’s reportable segments and address requests from investors for additional, more detailed information about a reportable segment’s expenses. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. Adoption of the standard requires using the retrospective approach. We are currently evaluating the potential impact of adopting this guidance on our consolidated financial statements and accompanying notes.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments in this update address investor requests for more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This update also includes certain other amendments to improve the effectiveness of income tax disclosures. The ASU is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. Adoption of the standard should be applied on a prospective basis and retrospective application to all periods presented is permitted. We are currently evaluating the potential impact of adopting this guidance on our consolidated financial statements and accompanying notes.

XML

Accumulated Other Comprehensive Loss (Tables)

3 Months Ended

Mar. 31, 2024

Equity [Abstract]

Schedule of Accumulated Balances Related to Each Component of Accumulated Other Comprehensive Income (Loss)

The changes in accumulated other comprehensive loss by component were as follows:

(Dollars and accompanying footnotes in millions)	Foreign Currency Translation Adjustments		Pension and Other Postretirement Benefits(1)		Total
Balance as of December 31, 2023	$	(56.8)	$	(9.6)	$	(66.4)
Other comprehensive income (loss) before reclassifications	(9.2)		—		(9.2)
Amounts reclassified from accumulated other comprehensive loss	—		0.1		0.1
Net current-period other comprehensive income (loss)	(9.2)		0.1		(9.1)
Balance as of March 31, 2024	$	(66.0)	$	(9.5)	$	(75.5)
Balance as of December 31, 2022	$	(75.6)	$	(9.6)	$	(85.2)
Other comprehensive income (loss) before reclassifications	9.7		—		9.7
Amounts reclassified from accumulated other comprehensive loss	—		—		—
Net current-period other comprehensive income (loss)	9.7		—		9.7
Balance as of March 31, 2023	$	(65.9)	$	(9.6)	$	(75.5)

(1) Net of taxes of $1.8 million for both March 31, 2024 and December 31, 2023. Net of taxes of $1.9 million for both March 31, 2023 and December 31, 2022.

XML

Derivatives and Hedging (Tables)

3 Months Ended

Mar. 31, 2024

Fair Value Disclosures [Abstract]

Schedule of Notional Amounts of Outstanding Derivative Positions

As of March 31, 2024, the notional values of the remaining foreign currency forward contracts were as follows:

Notional Values of Foreign Currency Derivatives
USD/CNH	$	20,700,000
EUR/USD	€	14,700,000
KRW/USD	₩	5,372,800,000
JPY/EUR	¥	250,000,000

As of March 31, 2024, the volume of our copper contracts outstanding was as follows:

Volume of Copper Derivatives
April 2024 - June 2024	69 metric tons per month
July 2024 - September 2024	69 metric tons per month
October 2024 - December 2024	69 metric tons per month
January 2025 - March 2025	69 metric tons per month

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance

The impacts from our derivative instruments on the statement of operations and statements of comprehensive income were as follows:

		Three Months Ended
(Dollars in millions)	Financial Statement Line Item	March 31, 2024		March 31, 2023
Foreign Currency Contracts
Contracts not designated as hedging instruments	Other income (expense), net	$	(0.1)	$	—
Copper Derivative Contracts
Contracts not designated as hedging instruments	Other income (expense), net	$	—	$	—

Schedule of Derivative Instruments Measured at Fair Value on a Recurring Basis

The fair values of derivative instruments measured at fair value on a recurring basis, categorized by contract type and level of inputs used in the valuation, were as follows:

	Derivative Instruments at Fair Value as of March 31, 2024
(Dollars in millions)	Level 1		Level 2		Level 3		Total(1)
Foreign currency contracts	$	—	$	(0.1)	$	—	$	(0.1)
Copper derivative contracts	$	—	$	0.5	$	—	$	0.5

	Derivative Instruments at Fair Value as of December 31, 2023
(Dollars in millions)	Level 1		Level 2		Level 3		Total(1)
Foreign currency contracts	$	—	$	(0.2)	$	—	$	(0.2)
Copper derivative contracts	$	—	$	0.4	$	—	$	0.4

(1) All balances were recorded in the “Other current assets” or “Other accrued liabilities” line items in the condensed consolidated statements of financial position.

XML

Inventories (Tables)

3 Months Ended

Mar. 31, 2024

Inventory Disclosure [Abstract]

Schedule of Inventories

The “Inventories, net” line item in the condensed consolidated statements of financial position consisted of the following:

(Dollars in millions)	March 31, 2024		December 31, 2023
Raw materials	$	76.5	$	71.5
Work-in-process	41.6		45.6
Finished goods	32.8		36.4
Total inventories	$	150.9	$	153.5

XML

Balance Sheet Items (Tables)

3 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Restricted Cash

Our restricted cash balance as of March 31, 2024 and December 31 2023 was as follows:

(Dollars in millions)	March 31, 2024		December 31, 2023
Restricted Cash	$	2.2	$	2.2

Schedule of Accounts Receivable

The “Accounts receivable, net” line item in the condensed consolidated statements of financial position consisted of the following:

(Dollars in millions)	March 31, 2024		December 31, 2023
Accounts Receivable - Trade	$	146.6	$	143.2
Accounts Receivable - Other	12.6		18.7
Total	$	159.2	$	161.9

Schedule of Accounts Payable

The “Accounts payable” line item in the condensed consolidated statements of financial position consisted of the following:

(Dollars in millions)	March 31, 2024		December 31, 2023
Accounts Payable - Trade	$	47.6	$	46.3
Accounts Payable - Other	4.1		4.0
Total	$	51.7	$	50.3

XML

Leases (Tables)

3 Months Ended

Mar. 31, 2024

Leases [Abstract]

Schedule of Lease Expense, Payments for Operating Leases, and Information Related to Lease Term and Discount Rates

Our expenses and payments for operating leases were as follows:

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Operating leases expense	$	1.3	$	1.0
Short-term leases expense	$	0.2	$	0.1
Payments on operating lease obligations	$	1.0	$	0.8

The following table includes information regarding the lease term and discount rates utilized in the calculation of the present value of net future minimum lease payments:

	March 31, 2024	December 31, 2023
Weighted Average Remaining Lease Term
Finance leases	3.9 years	4.0 years
Operating leases	6.7 years	7.0 years
Weighted Average Discount Rate
Finance leases	4.22%	4.14%
Operating leases	5.37%	5.35%

Schedule of Assets and Liabilities Balance Related To Finance and Operating Leases

The assets and liabilities balances related to finance and operating leases reflected in the condensed consolidated statements of financial position were as follows:

(Dollars in millions)	Financial Statement Line Item	March 31, 2024		December 31, 2023
Finance lease right-of-use assets	Property, plant and equipment, net	$	1.4	$	1.5
Operating lease right-of-use assets	Operating lease right-of-use assets	$	18.6	$	18.9
Finance lease obligations, current portion	Other accrued liabilities	$	0.4	$	0.4
Finance lease obligations, non-current portion	Other long-term liabilities	$	1.0	$	1.1
Total finance lease obligations		$	1.4	$	1.5
Operating lease obligations, current portion	Operating lease obligations, current portion	$	3.8	$	3.5
Operating lease obligations, non-current portion	Operating lease obligations, non-current portion	$	15.1	$	15.4
Total operating lease obligations		$	18.9	$	18.9

Schedule of Finance Lease Liability Maturity

The following table includes future minimum lease payments under finance and operating leases together with the present value of the net future minimum lease payments as of March 31, 2024:

	Finance						Operating
(Dollars in millions)	Leases Signed		Less: Leases Not Yet Commenced		Leases in Effect		Leases Signed		Less: Leases Not Yet Commenced		Leases in Effect
2024	$	0.3	$	—	$	0.3	$	3.9	$	(0.1)	$	3.8
2025	1.5		(1.1)		0.4		5.2		(1.1)		4.1
2026	1.6		(1.2)		0.4		4.5		(1.2)		3.3
2027	1.4		(1.2)		0.2		3.7		(1.1)		2.6
2028	1.3		(1.2)		0.1		2.6		(0.8)		1.8
Thereafter	5.1		(5.0)		0.1		11.9		(4.8)		7.1
Total lease payments	11.2		(9.7)		1.5		31.8		(9.1)		22.7
Less: Interest	(1.8)		1.7		(0.1)		(6.1)		2.3		(3.8)
Present Value of Net Future Minimum Lease Payments	$	9.4	$	(8.0)	$	1.4	$	25.7	$	(6.8)	$	18.9

Schedule of Operating Lease Liability Maturity

The following table includes future minimum lease payments under finance and operating leases together with the present value of the net future minimum lease payments as of March 31, 2024:

	Finance						Operating
(Dollars in millions)	Leases Signed		Less: Leases Not Yet Commenced		Leases in Effect		Leases Signed		Less: Leases Not Yet Commenced		Leases in Effect
2024	$	0.3	$	—	$	0.3	$	3.9	$	(0.1)	$	3.8
2025	1.5		(1.1)		0.4		5.2		(1.1)		4.1
2026	1.6		(1.2)		0.4		4.5		(1.2)		3.3
2027	1.4		(1.2)		0.2		3.7		(1.1)		2.6
2028	1.3		(1.2)		0.1		2.6		(0.8)		1.8
Thereafter	5.1		(5.0)		0.1		11.9		(4.8)		7.1
Total lease payments	11.2		(9.7)		1.5		31.8		(9.1)		22.7
Less: Interest	(1.8)		1.7		(0.1)		(6.1)		2.3		(3.8)
Present Value of Net Future Minimum Lease Payments	$	9.4	$	(8.0)	$	1.4	$	25.7	$	(6.8)	$	18.9

XML

Goodwill and Other Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill

The changes in the net carrying amount of goodwill by operating segment were as follows:

(Dollars in millions)	Advanced Electronics Solutions		Elastomeric Material Solutions		Other		Total
December 31, 2023	$	117.7	$	239.9	$	2.2	$	359.8
Foreign currency translation adjustment	(1.5)		(1.1)		—		$	(2.6)
March 31, 2024	$	116.2	$	238.8	$	2.2	$	357.2

Schedule of Intangible Assets

The carrying amount of other intangible assets were as follows:

	March 31, 2024						December 31, 2023
(Dollars in millions)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Customer relationships	$	177.0	$	91.4	$	85.6	$	177.9	$	90.0	$	87.9
Technology	76.8		58.6		18.2		77.4		58.1		19.3
Trademarks and trade names	19.3		7.4		11.9		19.4		7.4		12.0
Covenants not to compete	1.3		1.0		0.3		1.3		0.9		0.4
Total definite-lived other intangible assets	274.4		158.4		116.0		276.0		156.4		119.6
Indefinite-lived other intangible asset	4.3		—		4.3		4.3		—		4.3
Total other intangible assets	$	278.7	$	158.4	$	120.3	$	280.3	$	156.4	$	123.9

Schedule of Weighted Average Amortization Period, by Intangible Asset Class

The weighted average amortization period as of March 31, 2024, by definite-lived other intangible asset class, is presented in the table below:

	Weighted Average Remaining Amortization Period
Customer relationships	7.3 years
Technology	3.2 years
Trademarks and trade names	9.8 years
Covenants not to compete	0.4 years
Total definite-lived other intangible assets	6.9 years

XML

Pension Benefits and Other Postretirement Benefits (Tables)

3 Months Ended

Mar. 31, 2024

Retirement Benefits [Abstract]

Schedule of Components of Net Periodic Benefit Cost

The components of net periodic benefit (credit) cost were as follows:

	Pension Benefits
	Three Months Ended
	March 31,
(Dollars in millions)	2024		2023
Interest cost	0.2		0.3
Expected return of plan assets	(0.3)		(0.4)
Amortization of net loss (gain)	0.1		0.1
Net periodic benefit cost (credit)	$	—	$	—

XML

Commitments and Contingencies (Tables)

3 Months Ended

Mar. 31, 2024

Commitments and Contingencies Disclosure [Abstract]

Schedule of Liability For Unpaid Claims And Claims Adjustment Expense

The following table summarizes the change in number of asbestos claims outstanding for the three months ended March 31, 2024:

	Asbestos Claims
Claims outstanding as of January 1, 2024	506
New claims filed	35
Pending claims concluded(1)	(36)
Claims outstanding as of March 31, 2024	505

(1) For the three months ended March 31, 2024, 32 claims were dismissed and 4 claims were settled. Settlements totaled approximately $1.5 million for the three months ended March 31, 2024.

Schedule of Asbestos-Related Claims and Insurance Receivables

Our projected asbestos-related liabilities and insurance receivables were as follows:

(Dollars in millions)	March 31, 2024		December 31, 2023
Asbestos-related liabilities	$	61.5	$	61.5
Asbestos-related insurance receivables	$	56.5	$	56.5

XML

Earnings Per Share (Tables)

3 Months Ended

Mar. 31, 2024

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share:

(Dollars and shares in millions, except per share amounts)	Three Months Ended
	March 31, 2024		March 31, 2023
Numerator:
Net income (loss)	$	7.8	$	(3.5)
Denominator:
Weighted-average shares outstanding - basic	18.6		18.6
Effect of dilutive shares	0.1		—
Weighted-average shares outstanding - diluted	18.7		18.6
Basic earnings (loss) per share	$	0.42	$	(0.19)
Diluted earnings (loss) per share	$	0.42	$	(0.19)

XML

Capital Stock and Equity Compensation (Tables)

3 Months Ended

Mar. 31, 2024

Share-Based Payment Arrangement, Noncash Expense [Abstract]

Schedule of Stockholders Equity

(Dollars in millions, except shares and per share amounts)
Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet be Purchased under the Plans or Programs
March 1, 2024 to March 31, 2024	1,500	$	109.92	1,500	$	23.8

Schedule of Weighted-Average Assumptions Used

The following table sets forth the assumptions used in the Monte Carlo calculation for each material award granted in 2024 and 2023:

	February 19, 2024	February 13, 2024	February 9, 2023
Expected volatility	46.3%	46.2%	53.2%
Expected term (in years)	2.9	2.9	2.9
Risk-free interest rate	4.35%	4.35%	4.08%

Schedule of Restricted Stock and Restricted Stock Activity

A summary of activity of the outstanding performance-based restricted stock units for the three months ended March 31, 2024 is presented below:

	Performance-Based Restricted Stock Units
Awards outstanding as of December 31, 2023	73,528
Awards granted	79,700
Stock issued	—
Awards cancelled	(26,737)
Awards outstanding as of March 31, 2024	126,491

A summary of activity of the outstanding time-based restricted stock units for the three months ended March 31, 2024 is presented below:

	Time-Based Restricted Stock Units
Awards outstanding as of December 31, 2023	100,999
Awards granted	67,480
Stock issued	(34,261)
Awards cancelled	(3,688)
Awards outstanding as of March 31, 2024	130,530

A summary of activity of the outstanding deferred stock units for the three months ended March 31, 2024 is presented below:

	Deferred Stock Units
Awards outstanding as of December 31, 2023	8,100
Awards granted	450
Stock issued	(950)
Awards outstanding as of March 31, 2024	7,600

XML

Operating Segment Information (Tables)

3 Months Ended

Mar. 31, 2024

Segment Reporting [Abstract]

Schedule of Reportable Segment Information

The following table presents a disaggregation of revenue from contracts with customers and other pertinent financial information, for the periods indicated; inter-segment sales have been eliminated from the net sales data:

(Dollars in millions)	Advanced Electronics Solutions		Elastomeric Material Solutions		Other		Total
Three Months Ended March 31, 2024
Net sales - recognized over time	$	46.4	$	1.8	$	5.4	$	53.6
Net sales - recognized at a point in time	75.7		83.9		0.2		159.8
Total net sales	$	122.1	$	85.7	$	5.6	$	213.4
Operating income	$	4.4	$	5.3	$	2.0	$	11.7
Three Months Ended March 31, 2023
Net sales - recognized over time	$	62.4	$	9.0	$	3.9	$	75.3
Net sales - recognized at a point in time	73.5		93.2		1.8		168.5
Total net sales	$	135.9	$	102.2	$	5.7	$	243.8
Operating income	$	(5.5)	$	3.2	$	2.0	$	(0.3)

Net sales by operating segment and by geographic area were as follows:

(Dollars in millions)	Net Sales(1)
Region/Country	Advanced Electronics Solutions		Elastomeric Material Solutions		Other		Total
Three Months Ended March 31, 2024
United States	$	20.4	$	33.1	$	1.0	$	54.5
Other Americas	0.6		3.9		0.1		4.6
Total Americas	21.0		37.0		1.1		59.1
China	34.3		20.4		1.6		56.3
Other APAC	23.7		6.6		1.1		31.4
Total APAC	58.0		27.0		2.7		87.7
Germany	21.9		7.9		0.2		30.0
Other EMEA	21.2		13.8		1.6		36.6
Total EMEA	43.1		21.7		1.8		66.6
Total net sales	$	122.1	$	85.7	$	5.6	$	213.4
Three Months Ended March 31, 2023
United States	$	21.5	$	41.9	$	1.1	$	64.5
Other Americas	2.4		9.2		0.1		11.7
Total Americas	23.9		51.1		1.2		76.2
China	38.4		20.2		2.4		61.0
Other APAC	24.9		7.0		0.5		32.4
Total APAC	63.3		27.2		2.9		93.4
Germany	24.0		8.0		0.1		32.1
Other EMEA	24.7		15.9		1.5		42.1
Total EMEA	48.7		23.9		1.6		74.2
Total net sales	$	135.9	$	102.2	$	5.7	$	243.8

(1)Net sales are allocated to countries based on the location of the customer. The table above lists individual countries with 10% or more of net sales for the periods indicated.

Contract assets by operating segment were as follows:

(Dollars in millions)	March 31, 2024		December 31, 2023
Advanced Electronics Solutions	$	35.6	$	41.4
Elastomeric Material Solutions	0.7		0.4
Other	4.0		3.4
Total contract assets	$	40.3	$	45.2

XML

Supplemental Financial Information (Tables)

3 Months Ended

Mar. 31, 2024

Supplemental Income Statement Elements [Abstract]

Schedule of Restructuring and Impairment Charges

The components of the “Restructuring and impairment charges” line item in the condensed consolidated statements of operations were as follows:

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Restructuring charges
Global workforce reduction	$	—	$	7.0
Facility consolidations	0.1		3.5
Total restructuring charges	$	0.1	$	10.5
Total restructuring and impairment charges	$	0.1	$	10.5

The following table summarizes the allocation of restructuring and impairment charges to our operating segments:

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Advanced Electronics Solutions
Allocated restructuring charges	$	0.1	$	5.4
Elastomeric Material Solutions
Allocated restructuring charges	—		5.1
Total restructuring and impairment charges	$	0.1	$	10.5

Schedule of Other Operating (Income) Expense

The components of “Other operating (income) expense, net” line item in the condensed consolidated statements of operations, were as follows:

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
UTIS fire
Professional services	$	—	$	0.3
Insurance recoveries	—		(0.5)
Total UTIS fire	—		(0.2)
Total other operating (income) expense, net	$	—	$	(0.2)

Schedule of Components of Interest Expense, Net

The components of “Interest expense, net” line item in the condensed consolidated statements of operations, were as follows:

	Three Months Ended
(Dollars in millions)	March 31, 2024		March 31, 2023
Interest on revolving credit facility	$	(0.5)	$	(3.4)
Line of credit fees	(0.3)		(0.3)
Debt issuance amortization costs	(0.1)		(0.3)
Interest income	0.1		0.5
Total interest expense, net	$	(0.8)	$	(3.5)

XML

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance, beginning of period	$ 1,259.0
Other comprehensive income (loss) before reclassifications	(9.2)	$ 9.7
Amounts reclassified from accumulated other comprehensive loss	0.1	0.0
Other comprehensive income (loss)	(9.1)	9.7
Balance, end of period	1,259.8	1,178.3
Amortization of loss, net of tax (Note 2)	1.8	1.9
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance, beginning of period	(66.4)	(85.2)
Other comprehensive income (loss)	(9.1)	9.7
Balance, end of period	(75.5)	(75.5)
Foreign Currency Translation Adjustments
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance, beginning of period	(56.8)	(75.6)
Other comprehensive income (loss) before reclassifications	(9.2)	9.7
Amounts reclassified from accumulated other comprehensive loss	0.0	0.0
Other comprehensive income (loss)	(9.2)	9.7
Balance, end of period	(66.0)	(65.9)
Pension and Other Postretirement Benefits
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance, beginning of period	(9.6)	(9.6)
Other comprehensive income (loss) before reclassifications	0.0	0.0
Amounts reclassified from accumulated other comprehensive loss	0.1	0.0
Other comprehensive income (loss)	0.1	0.0
Balance, end of period	$ (9.5)	$ (9.6)

XML

Derivatives and Hedging (Notional Values of Derivative Instruments) (Details) - Contracts not designated as hedging instruments	Mar. 31, 2024 USD ($) tons_per_month	Mar. 31, 2024 EUR (€) tons_per_month	Mar. 31, 2024 KRW (₩) tons_per_month
April 2024 - June 2024
Derivative [Line Items]
Volume of Copper Derivatives (in metric tons per month)	69	69	69
July 2024 - September 2024
Derivative [Line Items]
Volume of Copper Derivatives (in metric tons per month)	69	69	69
October 2024 - December 2024
Derivative [Line Items]
Volume of Copper Derivatives (in metric tons per month)	69	69	69
January 2025 - March 2025
Derivative [Line Items]
Volume of Copper Derivatives (in metric tons per month)	69	69	69
USD/CNH | Foreign Currency Derivatives
Derivative [Line Items]
Notional Values of Foreign Currency Derivatives | $	$ 20,700,000
EUR/USD | Foreign Currency Derivatives
Derivative [Line Items]
Notional Values of Foreign Currency Derivatives | €		€ 14,700,000
KRW/USD | Foreign Currency Derivatives
Derivative [Line Items]
Notional Values of Foreign Currency Derivatives | ₩			₩ 5,372,800,000
JPY/EUR | Foreign Currency Derivatives
Derivative [Line Items]
Notional Values of Foreign Currency Derivatives | ₩			₩ 250,000,000

XML

Derivatives and Hedging (Additional Information) (Details)	Mar. 31, 2024 contract
Bank Term Loan
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of derivative contracts related to minimizing risk associated with potential rise in copper prices (in contracts)	12

XML

Derivatives and Hedging (Effect and Fair Value of Derivative Instruments) (Details) - Contracts not designated as hedging instruments - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Foreign Currency Contracts
Derivative [Line Items]
Derivative, gain (loss) on derivative, net	$ (0.1)	$ 0.0
Copper Derivative Contracts
Derivative [Line Items]
Derivative, gain (loss) on derivative, net	$ 0.0	$ 0.0

XML

Derivatives and Hedging (Various Instruments That Require Fair Value Measurement) (Details) - Fair Value, Measurements, Recurring - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Foreign currency contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of derivatives	$ (0.1)	$ (0.2)
Foreign currency contracts | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of derivatives	0.0	0.0
Foreign currency contracts | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of derivatives	(0.1)	(0.2)
Foreign currency contracts | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of derivatives	0.0	0.0
Copper derivative contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of derivatives	0.5	0.4
Copper derivative contracts | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of derivatives	0.0	0.0
Copper derivative contracts | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of derivatives	0.5	0.4
Copper derivative contracts | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of derivatives	$ 0.0	$ 0.0

XML

Inventories (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Raw materials	$ 76.5	$ 71.5
Work-in-process	41.6	45.6
Finished goods	32.8	36.4
Total inventories	$ 150.9	$ 153.5

XML

Balance Sheet Items (Restricted Cash) (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Restricted Cash	$ 2.2	$ 2.2

XML

Balance Sheet Items (Accounts Receivable) (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accounts Receivable - Trade	$ 146.6	$ 143.2
Accounts Receivable - Other	12.6	18.7
Total	$ 159.2	$ 161.9

XML

Balance Sheet Items (Accounts Payable) (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accounts Payable - Trade	$ 47.6	$ 46.3
Accounts Payable - Other	4.1	4.0
Total	$ 51.7	$ 50.3

XML

Leases (Payment for Operating Leases Expense) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Leases [Abstract]
Operating leases expense	$ 1.3	$ 1.0
Short-term leases expense	0.2	0.1
Payments on operating lease obligations	$ 1.0	$ 0.8

XML

Leases (Assets and Liabilities Balance Related to Finance and Operating Leases) (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Leases [Abstract]
Finance lease right-of-use assets	$ 1.4	$ 1.5
Operating lease right-of-use assets	18.6	18.9
Finance lease obligations, current portion	0.4	0.4
Finance lease obligations, non-current portion	1.0	1.1
Total finance lease obligations	1.4	1.5
Operating lease obligations, current portion	3.8	3.5
Operating lease obligations, non-current portion	15.1	15.4
Total operating lease obligations	$ 18.9	$ 18.9
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Property, plant and equipment, net of accumulated depreciation of $386.2 and $385.7	Property, plant and equipment, net of accumulated depreciation of $386.2 and $385.7
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Other accrued liabilities	Other accrued liabilities

XML

Leases (Future Minimum Lease Payments) (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Finance Leases Signed
2024	$ 0.3
2025	1.5
2026	1.6
2027	1.4
2028	1.3
Thereafter	5.1
Total lease payments	11.2
Less: Interest	(1.8)
Present Value of Net Future Minimum Lease Payments	9.4
Finance Leases Less: Leases Not Yet Commenced
2024	0.0
2025	(1.1)
2026	(1.2)
2027	(1.2)
2028	(1.2)
Thereafter	(5.0)
Total lease payments	(9.7)
Less: Interest	1.7
Present Value of Net Future Minimum Lease Payments	(8.0)
Finance Leases in Effect
2024	0.3
2025	0.4
2026	0.4
2027	0.2
2028	0.1
Thereafter	0.1
Total lease payments	1.5
Less: Interest	(0.1)
Total finance lease obligations	1.4	$ 1.5
Operating Leases Signed
2024	3.9
2025	5.2
2026	4.5
2027	3.7
2028	2.6
Thereafter	11.9
Total lease payments	31.8
Less: Interest	(6.1)
Present Value of Net Future Minimum Lease Payments	25.7
Operating Leases Less: Leases Not Yet Commenced
2024	(0.1)
2025	(1.1)
2026	(1.2)
2027	(1.1)
2028	(0.8)
Thereafter	(4.8)
Total lease payments	(9.1)
Less: Interest	2.3
Present Value of Net Future Minimum Lease Payments	(6.8)
Operating Leases in Effect
2024	3.8
2025	4.1
2026	3.3
2027	2.6
2028	1.8
Thereafter	7.1
Total lease payments	22.7
Less: Interest	(3.8)
Total operating lease obligations	$ 18.9	$ 18.9

XML

Leases (Lease Term and Discount Rate of Net Future Minimum Lease Payments) (Details)	Mar. 31, 2024	Mar. 31, 2023
Leases [Abstract]
Finance leases, weighted average remaining lease term (in years)	3 years 10 months 24 days	4 years
Operating leases, weighted average remaining lease term (in years)	6 years 8 months 12 days	7 years
Finance leases, weighted average discount rate (as a percent)	4.22%	4.14%
Operating leases, weighted average discount rate (as a percent)	5.37%	5.35%

XML

Goodwill and Other Intangible Assets (Changes in Carrying Amount of Goodwill by Segment) (Details) $ in Millions	3 Months Ended
	Mar. 31, 2024 USD ($)
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 359.8
Foreign currency translation adjustment	(2.6)
Goodwill, ending balance	357.2
Advanced Electronics Solutions
Goodwill [Roll Forward]
Goodwill, beginning balance	117.7
Foreign currency translation adjustment	(1.5)
Goodwill, ending balance	116.2
Elastomeric Material Solutions
Goodwill [Roll Forward]
Goodwill, beginning balance	239.9
Foreign currency translation adjustment	(1.1)
Goodwill, ending balance	238.8
Other
Goodwill [Roll Forward]
Goodwill, beginning balance	2.2
Foreign currency translation adjustment	0.0
Goodwill, ending balance	$ 2.2

XML

Goodwill and Other Intangible Assets (Intangible Assets) (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 274.4	$ 276.0
Indefinite-lived other intangible asset	4.3	4.3
Total other intangible assets, gross carrying amount	278.7	280.3
Accumulated Amortization	158.4	156.4
Net Carrying Amount	116.0	119.6
Total other intangible assets, net carrying amount	120.3	123.9
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	177.0	177.9
Accumulated Amortization	91.4	90.0
Net Carrying Amount	85.6	87.9
Technology
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	76.8	77.4
Accumulated Amortization	58.6	58.1
Net Carrying Amount	18.2	19.3
Trademarks and trade names
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	19.3	19.4
Accumulated Amortization	7.4	7.4
Net Carrying Amount	11.9	12.0
Covenants not to compete
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	1.3	1.3
Accumulated Amortization	1.0	0.9
Net Carrying Amount	$ 0.3	$ 0.4

XML

Goodwill and Other Intangible Assets (Additional Information) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 3.1	$ 3.3
Annual Future Amortization Expense
Anticipated future amortization expense for the remainder of 2024	9.3
Anticipated future amortization expense for 2025	10.8
Anticipated future amortization expense for 2026	10.4
Anticipated future amortization expense for 2027	10.0
Anticipated future amortization expense for 2028	$ 7.8

XML

Goodwill and Other Intangible Assets (Weighted Average Amortization Period by Intangible Asset Class) (Details)	Mar. 31, 2024
Acquired Finite-Lived Intangible Assets [Line Items]
Total definite-lived other intangible assets	6 years 10 months 24 days
Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Total definite-lived other intangible assets	7 years 3 months 18 days
Technology
Acquired Finite-Lived Intangible Assets [Line Items]
Total definite-lived other intangible assets	3 years 2 months 12 days
Trademarks and trade names
Acquired Finite-Lived Intangible Assets [Line Items]
Total definite-lived other intangible assets	9 years 9 months 18 days
Covenants not to compete
Acquired Finite-Lived Intangible Assets [Line Items]
Total definite-lived other intangible assets	4 months 24 days

XML

Pension Benefits and Other Postretirement Benefits (Additional Information) (Details)	3 Months Ended
	Mar. 31, 2024 USD ($) plan	Mar. 31, 2023 USD ($)
Defined Benefit Plan Disclosure [Line Items]
Number of qualified noncontributory defined benefit plans | plan	1
Pension Benefits | Merged Plan
Defined Benefit Plan Disclosure [Line Items]
Contributions	$ 0	$ 0
Pension Benefits | Union Plan
Defined Benefit Plan Disclosure [Line Items]
Additional contributions required to make for remainder of fiscal year	$ 0

XML

Pension Benefits and Other Postretirement Benefits (Components of Net Periodic Benefit (Credit) Cost) (Details) - Pension Benefits - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Interest cost	$ 0.2	$ 0.3
Expected return of plan assets	(0.3)	(0.4)
Amortization of net loss (gain)	0.1	0.1
Net periodic benefit cost (credit)	$ 0.0	$ 0.0

XML

Debt (Details)		3 Months Ended
	Mar. 24, 2023 USD ($) option	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)
Debt Instrument [Line Items]
Number of borrowings credit agreement interest options | option	2
Borrowings under revolving credit facility		$ 0		$ 30,000,000.0
Revolving Credit Facility
Debt Instrument [Line Items]
Borrowings under revolving credit facility		0		30,000,000
Outstanding line of credit issuance costs		$ 2,000,000		$ 2,100,000
Revolving Credit Facility | Fourth Amended and Restated Credit Agreement
Debt Instrument [Line Items]
Leverage ratio	3.25
One-time leverage ratio maximum option	3.75
One-time leverage ratio maximum option, period of increased maximum leverage ratio	1 year
ICR covenant limit	3.00
Amount of unrestricted domestic cash and cash equivalents permitted to net against indebtedness in calculation of total net leverage ratio (up to)	$ 50,000,000
Debt instrument, leverage ratio, maximum		2.75
Discretionary principal payments on revolving credit facility		$ 30,000,000	$ 25,000,000
Revolving Credit Facility | Fourth Amended and Restated Credit Agreement | Minimum
Debt Instrument [Line Items]
Unused capacity, commitment fee (as a percent)		0.25%
Revolving Credit Facility | Fourth Amended and Restated Credit Agreement | Maximum
Debt Instrument [Line Items]
Unused capacity, commitment fee (as a percent)		0.35%
Allowed restricted payments, including cash dividends		$ 20,000,000
Revolving Credit Facility | Fourth Amended and Restated Credit Agreement | Federal Funds Rate
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)		0.50%
Revolving Credit Facility | Fifth Amended and Restated Credit Agreement
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 450,000,000
Additional borrowing capacity		225,000,000
Variable rate lower range, basis spread	0.625%
Variable rate higher range, basis spread	1.00%
Proceeds from borrowings under revolving credit facility		$ 0
Revolving Credit Facility | Fifth Amended and Restated Credit Agreement | Eurocurrency loans
Debt Instrument [Line Items]
Line of credit, LIBOR rate, minimum basis spread (as a percent)	1.625%
Line of credit, LIBOR rate, maximum basis spread (as a percent)	2.00%
Revolving Credit Facility | Fifth Amended and Restated Credit Agreement | London Interbank Offered Rate (LIBOR) 1
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)		1.625%
Revolving Credit Facility | Fifth Amended and Restated Credit Agreement | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)		1.10%
Revolving Credit Facility | Fifth Amended and Restated Credit Agreement | Fed Funds Effective Rate Overnight Index Swap Rate
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)		0.50%

XML

Commitments and Contingencies (Change in Number of Asbestos Claims Outstanding) (Details) $ in Millions	3 Months Ended
	Mar. 31, 2024 USD ($) claim
Liability for Asbestos and Environmental Claims [Roll Forward]
Claims outstanding, beginning	506
New claims filed	35
Pending claims concluded	(36)
Claims outstanding, ending	505
Number of claims dismissed	32
Number of claims settled	4
Settlements | $	$ 1.5

XML

Commitments and Contingencies (Total Estimated Liability for Asbestos) (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Asbestos-related liabilities	$ 61.5	$ 61.5
Asbestos-related insurance receivables	$ 56.5	$ 56.5

XML

Commitments and Contingencies (Additional Information) (Details) - Connecticut Voluntary Corrective Action Program $ in Millions	3 Months Ended
	Mar. 31, 2024 USD ($)
Loss Contingencies [Line Items]
Environmental remediation expense incurred	$ 2.0
Accrual for future remediation efforts	$ 0.7

XML

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Numerator:
Net income (loss)	$ 7.8	$ (3.5)
Denominator:
Weighted-average shares outstanding - basic (in shares)	18.6	18.6
Effect of dilutive shares (in shares)	0.1	0.0
Weighted-average shares outstanding - diluted (in shares)	18.7	18.6
Basic earnings per share (in dollars per share)	$ 0.42	$ (0.19)
Diluted earnings per share (in dollars per share)	$ 0.42	$ (0.19)

XML

Capital Stock and Equity Compensation (Additional Information) (Details)	3 Months Ended
	Mar. 31, 2024 USD ($) offering_period shares	Mar. 31, 2023 USD ($)	Dec. 31, 2015 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Authorized stock repurchase amount			$ 100,000,000
Shares repurchased (in shares) | shares	1,500
Shares repurchased	$ 200,000
Remaining authorized stock repurchase amount	$ 23,800,000
Performance-Based Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock award program, measurement period (years)	3 years
Expected dividend yield (as a percent)	0.00%
Compensation expense	$ 1,300,000	$ (100,000)
Performance-Based Restricted Stock Units | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock award program, awarded shares as a percentage of the original award amount (as a percent)	0.00%
Performance-Based Restricted Stock Units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock award program, awarded shares as a percentage of the original award amount (as a percent)	200.00%
Time-Based Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 1,900,000	2,100,000
Conversion ratio	1
Deferred Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 0	$ 0
Conversion ratio	1
Vesting period	13 months
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 200,000
Number of offerings | offering_period	2
Offering period	6 months
Capital stock discount (as a percent)	15.00%
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock award program, measurement period (years)	2 years
Restricted Stock Units (RSUs) | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock award program, awarded shares as a percentage of the original award amount (as a percent)	0.00%
Restricted Stock Units (RSUs) | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock award program, awarded shares as a percentage of the original award amount (as a percent)	200.00%

XML

Capital Stock and Equity Compensation (Stockholders Equity) (Details) $ / shares in Units, $ in Millions	1 Months Ended
	Mar. 31, 2024 USD ($) $ / shares shares
Share-Based Payment Arrangement [Abstract]
Treasury stock acquired (in shares)	1,500
Treasury stock average cost (in dollars per share) | $ / shares	$ 109.92
Treasury stock acquired, publicly announced plans or programs (in shares)	1,500
Remaining authorized stock repurchase amount | $	$ 23.8

XML

Capital Stock and Equity Compensation (Monte Carlo Calculation Assumptions) (Details) - Performance-Based Restricted Stock Units	Feb. 19, 2024	Feb. 13, 2024	Feb. 09, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility (as a percent)	46.30%	46.20%	53.20%
Expected term (in years)	2 years 10 months 24 days	2 years 10 months 24 days	2 years 10 months 24 days
Risk-free interest rate (as a percent)	4.35%	4.35%	4.08%

XML

Capital Stock and Equity Compensation (Performance-Based Restricted Stock Awards) (Details) - Performance-Based Restricted Stock Units	3 Months Ended
	Mar. 31, 2024 shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Awards outstanding beginning balance (in shares)	73,528
Awards granted (in shares)	79,700
Stock issued (in shares)	0
Awards cancelled (in shares)	(26,737)
Awards outstanding ending balance (in shares)	126,491

XML

Capital Stock and Equity Compensation (Time-Based Restricted Stock Awards) (Details) - Time-Based Restricted Stock Units	3 Months Ended
	Mar. 31, 2024 shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Awards outstanding beginning balance (in shares)	100,999
Awards granted (in shares)	67,480
Stock issued (in shares)	(34,261)
Awards cancelled (in shares)	(3,688)
Awards outstanding ending balance (in shares)	130,530

XML

Capital Stock and Equity Compensation (Deferred Stock Units) (Details) - Deferred Stock Units - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Awards outstanding beginning balance (in shares)	8,100
Awards granted (in shares)	450
Stock issued (in shares)	(950)
Awards outstanding ending balance (in shares)	7,600
Compensation expense	$ 0.0	$ 0.0

XML

Operating Segment Information (Income by Reportable Segments) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Segment Reporting Information [Line Items]
Net sales	$ 213.4	$ 243.8
Operating income	11.7	(0.3)
Total Americas
Segment Reporting Information [Line Items]
Net sales	59.1	76.2
United States
Segment Reporting Information [Line Items]
Net sales	54.5	64.5
Other Americas
Segment Reporting Information [Line Items]
Net sales	4.6	11.7
Total APAC
Segment Reporting Information [Line Items]
Net sales	87.7	93.4
China
Segment Reporting Information [Line Items]
Net sales	56.3	61.0
Other APAC
Segment Reporting Information [Line Items]
Net sales	31.4	32.4
Total EMEA
Segment Reporting Information [Line Items]
Net sales	66.6	74.2
Germany
Segment Reporting Information [Line Items]
Net sales	30.0	32.1
Other EMEA
Segment Reporting Information [Line Items]
Net sales	36.6	42.1
Advanced Electronics Solutions
Segment Reporting Information [Line Items]
Net sales	122.1	135.9
Operating income	4.4	(5.5)
Advanced Electronics Solutions | Total Americas
Segment Reporting Information [Line Items]
Net sales	21.0	23.9
Advanced Electronics Solutions | United States
Segment Reporting Information [Line Items]
Net sales	20.4	21.5
Advanced Electronics Solutions | Other Americas
Segment Reporting Information [Line Items]
Net sales	0.6	2.4
Advanced Electronics Solutions | Total APAC
Segment Reporting Information [Line Items]
Net sales	58.0	63.3
Advanced Electronics Solutions | China
Segment Reporting Information [Line Items]
Net sales	34.3	38.4
Advanced Electronics Solutions | Other APAC
Segment Reporting Information [Line Items]
Net sales	23.7	24.9
Advanced Electronics Solutions | Total EMEA
Segment Reporting Information [Line Items]
Net sales	43.1	48.7
Advanced Electronics Solutions | Germany
Segment Reporting Information [Line Items]
Net sales	21.9	24.0
Advanced Electronics Solutions | Other EMEA
Segment Reporting Information [Line Items]
Net sales	21.2	24.7
Elastomeric Material Solutions
Segment Reporting Information [Line Items]
Net sales	85.7	102.2
Operating income	5.3	3.2
Elastomeric Material Solutions | Total Americas
Segment Reporting Information [Line Items]
Net sales	37.0	51.1
Elastomeric Material Solutions | United States
Segment Reporting Information [Line Items]
Net sales	33.1	41.9
Elastomeric Material Solutions | Other Americas
Segment Reporting Information [Line Items]
Net sales	3.9	9.2
Elastomeric Material Solutions | Total APAC
Segment Reporting Information [Line Items]
Net sales	27.0	27.2
Elastomeric Material Solutions | China
Segment Reporting Information [Line Items]
Net sales	20.4	20.2
Elastomeric Material Solutions | Other APAC
Segment Reporting Information [Line Items]
Net sales	6.6	7.0
Elastomeric Material Solutions | Total EMEA
Segment Reporting Information [Line Items]
Net sales	21.7	23.9
Elastomeric Material Solutions | Germany
Segment Reporting Information [Line Items]
Net sales	7.9	8.0
Elastomeric Material Solutions | Other EMEA
Segment Reporting Information [Line Items]
Net sales	13.8	15.9
Other
Segment Reporting Information [Line Items]
Net sales	5.6	5.7
Operating income	2.0	2.0
Other | Total Americas
Segment Reporting Information [Line Items]
Net sales	1.1	1.2
Other | United States
Segment Reporting Information [Line Items]
Net sales	1.0	1.1
Other | Other Americas
Segment Reporting Information [Line Items]
Net sales	0.1	0.1
Other | Total APAC
Segment Reporting Information [Line Items]
Net sales	2.7	2.9
Other | China
Segment Reporting Information [Line Items]
Net sales	1.6	2.4
Other | Other APAC
Segment Reporting Information [Line Items]
Net sales	1.1	0.5
Other | Total EMEA
Segment Reporting Information [Line Items]
Net sales	1.8	1.6
Other | Germany
Segment Reporting Information [Line Items]
Net sales	0.2	0.1
Other | Other EMEA
Segment Reporting Information [Line Items]
Net sales	1.6	1.5
Recognized over time
Segment Reporting Information [Line Items]
Net sales	53.6	75.3
Recognized over time | Advanced Electronics Solutions
Segment Reporting Information [Line Items]
Net sales	46.4	62.4
Recognized over time | Elastomeric Material Solutions
Segment Reporting Information [Line Items]
Net sales	1.8	9.0
Recognized over time | Other
Segment Reporting Information [Line Items]
Net sales	5.4	3.9
Recognized at a point in time
Segment Reporting Information [Line Items]
Net sales	159.8	168.5
Recognized at a point in time | Advanced Electronics Solutions
Segment Reporting Information [Line Items]
Net sales	75.7	73.5
Recognized at a point in time | Elastomeric Material Solutions
Segment Reporting Information [Line Items]
Net sales	83.9	93.2
Recognized at a point in time | Other
Segment Reporting Information [Line Items]
Net sales	$ 0.2	$ 1.8

XML

Operating Segment Information (Contract Assets By Operating Segments) (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Segment Reporting Information [Line Items]
Total contract assets	$ 40.3	$ 45.2
Advanced Electronics Solutions
Segment Reporting Information [Line Items]
Total contract assets	35.6	41.4
Elastomeric Material Solutions
Segment Reporting Information [Line Items]
Total contract assets	0.7	0.4
Other
Segment Reporting Information [Line Items]
Total contract assets	$ 4.0	$ 3.4

XML

Supplemental Financial Information (Restructuring and Impairment Charges) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 100	$ 10,500
Total restructuring and impairment charges	100	10,500
Global workforce reduction
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	7,000
Facility consolidations
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 100	$ 3,500

XML

Supplemental Financial Information (Additional Information) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Feb. 16, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring expenses expected to incur	$ 8,200		$ 8,800
Operating segment for a purchase price	1,800
Disposal group, including discontinued operation, consideration phase one	1,000
Disposal group, including discontinued operation, consideration phase two	800
Disposal group, including discontinued operation, assets	3,700
Disposal group, including discontinued operation, liabilities	3,100
Disposal group, including discontinued operation, selling costs		$ 1,200
Net book value of assets held-and-used	13,100
Gain on sale of properties	1,900
Insurance recoveries	0	(500)
Professional services	0	$ 300
Suzhou, China Facilities
Restructuring Cost and Reserve [Line Items]
Net book value of assets held-and-used	3,000
Proceeds from sale of buildings	$ 6,800

XML

Supplemental Financial Information (Allocation of Restructuring and Impairment Charges to Operating Segments) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Restructuring Cost and Reserve [Line Items]
Total restructuring and impairment charges	$ 100	$ 10,500
Allocated restructuring charges | Advanced Electronics Solutions
Restructuring Cost and Reserve [Line Items]
Total restructuring and impairment charges	100	5,400
Allocated restructuring charges | Elastomeric Material Solutions
Restructuring Cost and Reserve [Line Items]
Total restructuring and impairment charges	$ 0	$ 5,100

XML

Supplemental Financial Information (Other Operating (Income) Expense, Net) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
UTIS fire
Professional services	$ 0	$ 300
Insurance recoveries	0	(500)
Total UTIS fire	0	(200)
Other operating (income) expense, net	$ 0	$ (200)

XML

Supplemental Financial Information (Interest Expense) (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Supplemental Income Statement Elements [Abstract]
Interest on revolving credit facility	$ (500)	$ (3,400)
Line of credit fees	(300)	(300)
Debt issuance amortization costs	(100)	(300)
Interest income	100	500
Total interest expense, net	$ (800)	$ (3,500)

XML

Income Taxes (Details)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Effective tax rate (as a percent)	32.80%	3.50%